# EDGAR Filing Document

**Accession Number:** 0001847986
**File Stem:** 0001493152-25-011982
**Filing Date:** 2025-8
**Character Count:** 250001
**Document Hash:** eaebd96f8eb0474c7f9fa89d31f12a77
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-011982.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001493152-25-011982

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 80

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dragonfly Energy Holdings Corp.
- **CENTRAL INDEX KEY:** 0001847986
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 851873463
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40730
- **FILM NUMBER:** 251219139

**BUSINESS ADDRESS:**
- **STREET 1:** 12915 OLD VIRGINIA ROAD
- **CITY:** RENO,
- **STATE:** NV
- **ZIP:** 89521
- **BUSINESS PHONE:** (775) 622-3448

**MAIL ADDRESS:**
- **STREET 1:** 12915 OLD VIRGINIA ROAD
- **CITY:** RENO,
- **STATE:** NV
- **ZIP:** 89521

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Chardan NexTech Acquisition 2 Corp.
- **DATE OF NAME CHANGE:** 20210225

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended: June 30, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from: _________________ to ___________________**

**Commission File Number: <u>001-40730</u>**

**DRAGONFLY ENERGY HOLDINGS CORP.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **85-1873463** |
| (State or other jurisdiction of | (IRS Employer |
| incorporation or organization) | Identification No.) |

---

---

| | |
|:---|:---|
| **12915 Old Virginia Road**<br>**Reno, Nevada** | **89521** |
| (Address of principal executive offices) | (Zip Code) |

---

**<u>(775) 622-3448</u>**

(Registrant's telephone number, including area code)

**<u>N/A</u>**

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.0001 per share | DFLI | The Nasdaq Capital Market |
| Redeemable Warrants, exercisable for common stock | DFLIW | The Nasdaq Capital Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of Aug 11, 2025, there were 61,724,593 shares of the registrant's common stock, par value $0.0001 per share, issued and outstanding.

**DRAGONFLY ENERGY HOLDINGS CORP.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page No.** |
| [**PART I. FINANCIAL INFORMATION**](#ab_001) | [**PART I. FINANCIAL INFORMATION**](#ab_001) |  |
| Item 1. | Financial Statements (Unaudited) |  |
|  | [Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024](#a_001) | 3 |
|  | [Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2025 and 2024](#a_002) | 4 |
|  | [Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the three and six months ended June 30, 2025 and 2024](#a_003) | 5 |
|  | [Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 2024](#a_004) | 6 |
|  | [Notes to Condensed Consolidated Financial Statements](#a_005) | 8 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_006) | 45 |
| Item 3. | [Quantitative and Qualitative Disclosures about Market Risk](#a_007) | 66 |
| Item 4. | [Controls and Procedures](#a_008) | 66 |
| **[PART II. OTHER INFORMATION](#a_009)** | **[PART II. OTHER INFORMATION](#a_009)** |  |
| Item 1. | [Legal Proceedings](#a_010) | 67 |
| Item 1A. | [Risk Factors](#a_011) | 67 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#a_012) | 67 |
| Item 3. | [Defaults Upon Senior Securities](#a_013) | 67 |
| Item 4. | [Mine Safety Disclosures](#a_014) | 67 |
| Item 5. | [Other Information](#a_015) | 68 |
| Item 6. | [Exhibits](#a_016) | 68 |
| [Signatures](#a_017) | [Signatures](#a_017) | 69 |

---

**Dragonfly Energy Holdings Corp.**

**condensed Consolidated Balance Sheets**

**(in thousands, except share and per share data)**

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 Unaudited | December 31, 2024 |
| **Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2733 | $4849 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for credit losses | 3569 | 2416 |
| &nbsp;&nbsp;&nbsp;Inventory | 21053 | 21716 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | 846 | 806 |
| &nbsp;&nbsp;&nbsp;Prepaid inventory | 1514 | 1362 |
| &nbsp;&nbsp;&nbsp;Prepaid income tax | 311 | 307 |
| &nbsp;&nbsp;&nbsp;Assets held for sale |  | 644 |
| &nbsp;&nbsp;&nbsp;Other current assets | 761 | 825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets | 30787 | 32925 |
| **Property and Equipment** |  |  |
| &nbsp;&nbsp;&nbsp;Machinery and equipment | 17551 | 16778 |
| &nbsp;&nbsp;&nbsp;Office furniture and equipment | 419 | 355 |
| &nbsp;&nbsp;&nbsp;Leasehold improvements | 8990 | 9103 |
| &nbsp;&nbsp;&nbsp;Vehicle | 33 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 26993 | 26269 |
| &nbsp;&nbsp;&nbsp;Less accumulated depreciation and amortization | (5512) | (4162) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and Equipment, Net | 21481 | 22107 |
| Operating lease right of use asset, net | 19055 | 19737 |
| Other assets | 451 | 445 |
| &nbsp;&nbsp;&nbsp;**Total Assets** | $71774 | $75214 |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $9858 | $10716 |
| &nbsp;&nbsp;&nbsp;Accrued payroll and other liabilities | 4278 | 4129 |
| &nbsp;&nbsp;&nbsp;Accrued tariffs | 2211 | 1915 |
| &nbsp;&nbsp;&nbsp;Accrued settlement, current portion | 1438 | 750 |
| &nbsp;&nbsp;&nbsp;Customer deposits | 166 | 317 |
| &nbsp;&nbsp;&nbsp;Deferred revenue, current portion | 1000 | 1000 |
| &nbsp;&nbsp;&nbsp;Uncertain tax position liability | 55 | 55 |
| &nbsp;&nbsp;&nbsp;Notes payable, current portion, net of debt issuance costs | 393 |  |
| &nbsp;&nbsp;&nbsp;Operating lease liability, current portion | 2949 | 2926 |
| &nbsp;&nbsp;&nbsp;Financing lease liability, current portion | 48 | 47 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Liabilities | 22396 | 21855 |
| **Long-Term Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Deferred revenue, net of current portion | 3083 | 3583 |
| &nbsp;&nbsp;&nbsp;Warrant liabilities | 322 | 5133 |
| &nbsp;&nbsp;&nbsp;Accrued settlement, net of current portion | 875 | 1750 |
| &nbsp;&nbsp;&nbsp;Notes payable, non current portion, net of debt issuance costs | 38647 | 29646 |
| &nbsp;&nbsp;&nbsp;Operating lease liability, net of current portion | 21771 | 22588 |
| &nbsp;&nbsp;&nbsp;Financing lease liability, net of current portion | 39 | 63 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Long-Term Liabilities | 64737 | 62763 |
| &nbsp;&nbsp;&nbsp;**Total Liabilities** | 87133 | 84618 |
| **Commitments and Contingencies (See Note 5)** |  |  |
| **Redeemable Preferred Stock** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock - Series A, 5,000 shares at $0.0001 par value, authorized, 136 and 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 1245 |  |
| **Stockholders' (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock - Undesignated, 4,995,000 shares at $0.0001 par value, authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, 400,000,000 shares at $0.0001 par value, authorized, <br>37,426,379 and 7,232,650 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 4 | 1 |
| Additional paid in capital | 79377 | 72749 |
| Accumulated deficit | (95985) | (82154) |
| **Total Stockholders' (Deficit)** | (16604) | (9404) |
| Total Liabilities, Redeemable Preferred Stock and Stockholders' (Deficit) | $71774 | $75214 |

---

*The accompanying notes are an integral part of the consolidated financial statements.*

 

**Dragonfly Energy Holdings Corp.**

**Unaudited condensed Consolidated Statements of Operations**

**For the Three and Six Months Ended June 30, 2025 and 2024**

**(in thousands, except share and per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For The Three Months Ended<br> June 30,  | For The Three Months Ended<br> June 30,  | For The Six Months Ended<br> June 30,  | For The Six Months Ended<br> June 30,  |
|  | 2025 | 2024 | 2025 | 2024 |
| **Net Sales** | $16248 | $13208 | $29604 | $25713 |
| **Cost of Goods Sold** | 11643 | 10041 | 21071 | 19495 |
| **Gross Profit** | 4605 | 3167 | 8533 | 6218 |
| **Operating Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 692 | 1531 | 1692 | 2864 |
| &nbsp;&nbsp;&nbsp;General and administrative | 4619 | 5704 | 10976 | 10517 |
| &nbsp;&nbsp;&nbsp;Selling and marketing | 2575 | 2681 | 5060 | 5425 |
| **Total Operating Expenses** | 7886 | 9916 | 17728 | 18806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Loss From Operations** | (3281) | (6749) | (9195) | (12588) |
| **Other (Expense) Income** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (5442) | (4878) | (10143) | (9638) |
| &nbsp;&nbsp;&nbsp;Other expense |  | (19) |  | (23) |
| &nbsp;&nbsp;&nbsp;Change in fair market value of warrant liability | 1689 | (1981) | 5507 | (1745) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Expense** | (3753) | (6878) | (4636) | (11406) |
| **Net Loss Before Taxes** | (7034) | (13627) | (13831) | (23994) |
| **Income Tax Expense (Benefit)** | - | - | - | - |
| **Net Loss** | $(7034) | $(13627) | $(13831) | $(23994) |
| Loss Per Share- Basic & Diluted | $(0.58) | $(2.02) | $(1.42) | $(3.57) |
| Weighted Average Number of Shares - Basic & Diluted | 12188071 | 6741537 | 9759302 | 6718627 |

---

*The accompanying notes are an integral part of the consolidated financial statements.*

 

**Dragonfly Energy Holdings Corp.**

**Unaudited Condensed Consolidated Statements of Shareholders' Equity (Deficit)**

**For The Three and Six Months Ended June 30, 2025 and 2024**

**(in thousands, except share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | Redeemable Preferred Stock | Redeemable Preferred Stock | Common Stock | Common Stock | | | |
|  | Shares | Amount | Shares | Amount | Additional Paid-In<br>Capital | Accumulated<br>(Deficit) |<br>Total |
| **Balance - January 1, 2025** | - | $- | 7232650 | $1 | $72749 | $(82154) | $(9404) |
| Net loss |  |  |  |  |  | (6797) | (6797) |
| Common stock issued in public offering (ATM), net of costs |  |  | 23160 |  | 63 |  | 63 |
| Redeemable preferred stock issued, net | 350 | 3180 |  |  |  |  |  |
| Shares issued for vested restricted stock units |  |  | 21945 |  |  |  |  |
| Conversion of preferred stock to common stock | (30) | (273) | 311887 |  | 273 |  | 273 |
| Stock compensation expense | - | - | - | - | 220 | - | 220 |
| **Balance - March 31, 2025** | 320 | 2907 | 7589642 | 1 | 73305 | (88951) | (15645) |
| Net loss |  |  |  |  |  | (7034) | (7034) |
| Share issuance under ESPP |  |  | 87506 |  | 73 |  | 73 |
| Redeemable preferred stock issued, net | 450 | 4150 |  |  |  |  |  |
| Shares issued for vested restricted stock units |  |  | 64343 |  |  |  |  |
| Conversion of preferred stock to common stock | (634) | (5812) | 29684888 | 3 | 5809 |  | 5812 |
| Stock compensation expense | - | - | - | - | 190 | - | 190 |
| **Balance - June 30, 2025** | 136 | $1245 | 37426379 | $4 | $79377 | $(95985) | $(16604) |
| **Balance - January 1, 2024** | - | $- | 6695587 | $1 | $69450 | $(41539) | $27912 |
| Net loss |  |  |  |  |  | (10367) | (10367) |
| Stock compensation expense | - | - | - | - | 266 | - | 266 |
| **Balance - March 31, 2024** |  |  | 6695587 | 1 | 69716 | (51906) | 17811 |
| Net loss |  |  |  |  |  | (13627) | (13627) |
| Common stock issued in public offering (ATM), net of costs |  |  | 94496 |  | 730 |  | 730 |
| Share issuance under ESPP |  |  | 27197 |  | 112 |  | 112 |
| Share cancellation |  |  | (49) |  |  |  |  |
| Exercise of stock options |  |  | 972 |  | 3 |  | 3 |
| Shares issued for vested restricted stock units |  |  | 423 |  |  |  |  |
| Stock compensation expense | - | - | - | - | 237 | - | 237 |
| **Balance - June 30, 2024** | - | $- | 6818626 | $1 | $70798 | $(65533) | $5266 |

---

*The accompanying notes are an integral part of the consolidated financial statements.*

**Dragonfly Energy Holdings Corp.**

**Unaudited Condensed Consolidated Statements of Cash Flows**

**For The Six Months Ended June 30, 2025 and 2024**

**(in thousands)**

---

| | | |
|:---|:---|:---|
|  | 2025 | 2024 |
| Cash flows from Operating Activities |  |  |
| Net (Loss) | $(13831) | $(23994) |
| Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock based compensation | 410 | 503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount | 2784 | 2428 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair market value of warrant liability | (5507) | 1745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest expense (paid-in kind) | 7306 | 4582 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 70 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 1350 | 663 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right of use of assets | 1324 | 1019 |
| Changes in Assets and Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | (1223) | (1246) |
| &nbsp;&nbsp;&nbsp;Inventories | 663 | 10125 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | (40) | (4) |
| &nbsp;&nbsp;&nbsp;Prepaid inventory | (152) | (595) |
| &nbsp;&nbsp;&nbsp;Other current assets | 64 | (632) |
| &nbsp;&nbsp;&nbsp;Other assets | (6) | (445) |
| &nbsp;&nbsp;&nbsp;Income taxes payable | (4) | 174 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 905 | (1890) |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | (1436) | (61) |
| &nbsp;&nbsp;&nbsp;Accrued tariffs | 296 | 150 |
| &nbsp;&nbsp;&nbsp;Accrued settlement | (187) |  |
| &nbsp;&nbsp;&nbsp;Deferred revenue | (500) |  |
| &nbsp;&nbsp;&nbsp;Customer deposits | (151) | 49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Adjustments | 5966 | 16583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Cash Used in Operating Activities | (7865) | (7411) |
| Cash Flows Used in Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (1621) | (1324) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Cash Used in Investing Activities | (1621) | (1324) |

---

*The accompanying notes are an integral part of the consolidated financial statements.*

**Dragonfly Energy Holdings Corp.**

**Unaudited Condensed Consolidated Statements of Cash Flows (Continued)**

**For The Six Months Ended June 30, 2025 and 2024**

**(in thousands)**

---

| | | |
|:---|:---|:---|
| (continued from previous page) | 2025 | 2024 |
| Cash Flows From Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from public offering (ATM), net | 63 | 788 |
| &nbsp;&nbsp;&nbsp;Payments from public offering costs |  | (51) |
| &nbsp;&nbsp;&nbsp;Proceeds from preferred stock offering, net of fees | 7330 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from note payable, related party |  | 2700 |
| &nbsp;&nbsp;&nbsp;Repayment of note payable, related party |  | (2700) |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of options |  | 3 |
| &nbsp;&nbsp;&nbsp;Financing lease liabilities | (23) | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Cash Provided by Financing Activities | 7370 | 721 |
| Net (Decrease) in cash and cash equivalents | (2116) | (8014) |
| Beginning Cash and cash equivalents - beginning of period | 4849 | 12713 |
| Ending Cash and cash equivalents - end of period | $2733 | $4699 |
| Supplemental Disclosures of Cash Flow Information: |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $4 | $- |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $3 | $4780 |
| Supplemental Non-Cash Items |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property and equipment, not yet paid | $162 | $2278 |
| &nbsp;&nbsp;&nbsp;Recognition of right of use asset obtained in exchange for operating lease liability | $642 | $18653 |
| &nbsp;&nbsp;&nbsp;Recognition of leasehold improvements obtained in exchange for operating lease liability | $- | $4683 |
| &nbsp;&nbsp;&nbsp;Recognition of warrant liability - Investor Warrants | $696 | $4796 |
| &nbsp;&nbsp;&nbsp;Conversion of preferred stock to common stock | $6085 | $- |
| &nbsp;&nbsp;&nbsp;Settlement of accrued liability for employee stock purchase plan | $73 | $112 |
| &nbsp;&nbsp;&nbsp;Reclassification of assets held for sale to machinery and equipment | $644 | $- |

---

*The accompanying notes are an integral part of the consolidated financial statements.*

**Dragonfly Energy Holdings Corp.**

**Notes to Unaudited Condensed Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 1 - Nature of Business**

Dragonfly Energy Holdings Corp. (the "Company") sells lithium ion battery packs for use in a wide variety of applications. The Company sells to distributors under the Dragonfly Energy brand name, and sells direct to consumers under the trade name Battleborn Batteries. In addition, the Company develops technology for improved lithium ion battery manufacturing and assembly methods.

**Note 2 – Summary of Significant Accounting Policies**

*<u>Principles of consolidation</u>*

 

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and present the consolidated financial statements of the Company and its wholly owned subsidiary, Dragonfly Energy Corp. All significant intercompany transactions and balances are eliminated in consolidation.

*<u>Basis of presentation</u>*

 

The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. GAAP for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (the "SEC") set forth in Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These condensed consolidated financial statements should be read along with the Annual Report on Form 10-K filed with the SEC on March 31, 2025 of the Company for the annual period ended December 31, 2024. The consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated financial statements as of and for the year then ended.

*<u>Going Concern</u>*

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Going Concern (Continued)</u>*

 

During the six months ended June 30, 2025 and 2024, the Company incurred losses from operations and had negative cash flow from operations. As of June 30, 2025, the Company had $2,733 in cash and cash equivalents and a working capital of $8,391. The Company's ability to achieve profitability and positive cash flow depends on its ability to increase revenue, contain its expenses and maintain compliance with the financial covenants in its outstanding indebtedness agreements.

In connection with the Company's senior secured term loan facility in an aggregate principal amount of $75,000 (as amended, the "Term Loan"), the Company is obligated to comply with certain financial covenants, which include maintaining a maximum senior leverage ratio, minimum liquidity, a springing fixed charge coverage ratio, and maximum capital expenditures **(See Note 6).** Between March 2024 and February 2025, the Company obtained multiple waivers from the Term Loan administrative agent and lenders, or the Term Loan Lenders, for noncompliance with the liquidity requirements under the Term Loan. As of February 2025, all financial covenants were removed through June 2026, except for the requirement to maintain cash and cash equivalents equal to or greater than $2,500 on a monthly basis.

On February 26, 2025, the Company entered into a Securities Purchase agreement ("Purchase Agreement"). The Purchase Agreement calls for the Company to authorize a new series of convertible preferred stock of the Company designated as the Series A Convertible Preferred Stock, which shall be convertible into shares of the Company's common stock, and sell to each Buyer an aggregate number of shares of Series A Preferred Stock and 20 warrants, to each buyer, that are convertible to common stock.

During the six months ended June 30, 2025, we received proceeds of $8,000 less $670 in costs, which the Company has been using for working capital and general corporate purposes. In addition, investors received warrants to purchase up to 4,000 shares of Series A Preferred Stock at $10,000 per share, potentially providing up to $40 million in future capital. Such warrants were cancelled on June 23, 2025 and are no longer outstanding.

Subsequent to June 30, 2025, on July 31, 2025, the Company received proceeds of $5,495 less $460 in costs, which the Company will use for working capital and other general corporate purposes, including the repayment of indebtedness in the ordinary course. Investors received an aggregate of 21,980,000 shares of common stock.

In addition to the Purchase Agreement, the Term Loan was amended to (i) extend the maturity date by one (1) year to October 2027, (ii) defer all principal and interest payments to April 2026 and (iii) remove any applicable financial covenants (except for a financial covenant requiring the Company to maintain cash and cash equivalents equal to or greater than $2,500) through June 30, 2026.

As presented above, strategic initiatives were executed in order to alleviate the substantial doubt, such as the Company's ability to raise funds through the Purchase Agreement, the maturity extension of the Term Loan, and the absence of any covenants, other than a $2,500 minimum cash requirement, for at least one year from the financial statement issuance date. While these initiatives were enough support to move the Company's debt to a long term classification, the initiatives were not enough support to completely alleviate the Company's going concern. Due to no other concessions being made by the lenders in terms of future debt and interest due, except for extending payments into 2026 and the maturity date by one year, and due to the inherent uncertainty surrounding the realization of projected revenues from new markets, management concluded that there is significant doubt about the Company's ability to continue as a going concern.

In addition, the Company may need to raise additional debt and/or equity financings to fund its operations, strategic plans, meet its financial covenants under the Term Loan and repay its outstanding indebtedness under the Term Loan. The Company has historically been able to raise additional capital through issuance of equity and/or debt financings and the Company intends to raise additional capital as needed. However, the Company cannot guarantee that it will be able to raise additional equity, contain expenses, or increase revenue, and comply with the financial covenants under the Term Loan. If the Company is unable to obtain additional funding to support its current or proposed activities and operations and its outstanding indebtedness, it may not be able to continue its operations as currently anticipated, which may require it to suspend or terminate any ongoing development activities, modify its business plan, curtail various aspects of its operations, cease operations, or seek relief under applicable bankruptcy laws. In such event, the Company's stockholders may lose a substantial portion or even all of their investment

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Cash and Cash Equivalents</u>*

 

The Company considers all short-term debt securities with a maturity of three months or less when purchased to be cash equivalents. As of June 30, 2025 and December 31, 2024, the Company held no Cash Equivalents.

From time to time the Company has amounts on deposit with financial institutions that exceed federally insured limits. The Company has not experienced any significant losses in such accounts.

*<u>Accounts Receivable</u>*

 

The Company's trade receivables are recorded when billed and represent claims against third parties that will be settled in cash. Generally, payment is due from customers within 30-90 days of the invoice date and the contracts do not have significant financing components. Trade accounts receivables are recorded gross and are net of any applicable allowance. The allowance for credit losses as of June 30, 2025 and December 31, 2024 were not material.

*<u>Inventory</u>*

 

Inventories **(Note 4),** which consist of raw materials and finished goods, are stated at the lower of cost (first in, first out) or net realizable value, net of reserves for obsolete inventory. The Company continually analyzes its slow moving and excess inventories. Based on historical and projected sales volumes and anticipated selling prices, the Company established reserves. Inventory that is in excess of current and projected use is reduced by an allowance to a level that approximates its estimate of future demand. Products that are determined to be obsolete are written down to net realizable value. The Company had a reserve of $300 and $188 as of June 30, 2025 and December 31, 2024, respectively.

*<u>Assets Held for Sale</u>*

 

Assets held for sale are valued at the lower of the carrying amount or the net realizable value estimated at June 30, 2025. Impairment to carrying amounts are recognized to non-operating expenses in the year ending December 31, 2024. The Assets held for sale, or the disposal group, consists of two research and development pieces of equipment that were not in use yet. Due to the nature of the disposal group being long-lived assets, the disposal group qualifies for the held for sale classification, as defined in ASC 360. Due to the Company shifting its focus from research and development efforts to product development, these assets would be put into service at an undeterminable time in the future and therefore, a search for a potential buyer was conducted. The sale was expected to be completed in the quarter ended June 30, 2025, but unforeseen circumstances forced the buyer to back out. Due to not being able to locate another buyer, the assets held for sale were reclassified as Property and Equipment as of June 30, 2025.

*<u>Use of Estimates</u>*

 

The preparation of financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company utilizes the use of estimates in its calculations for the reserve for obsolete or slow moving inventory, going concern, right of use asset, warrant liability, equity based compensation, income taxes, leases and license arrangement.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Revenue Recognition</u>*

 

Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer.

Revenue is recognized when control of the promised goods is transferred to the customer or reseller, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods and services. Revenue associated with products holding rights of return are recognized when the Company concludes there is not a risk of significant revenue reversal in the future periods for the expected consideration in the transaction. There are no material instances including discounts and refunds where variable consideration is constrained and not recorded at the initial time of sale. Generally, the Company's revenue is recognized at a point in time for standard promised goods at the time of shipment when title and risk of loss pass to the customer.

The Company recognizes revenue from right-to-access license agreements upon the transfer of control to the customer. Upfront fees are deferred and recognized over the estimated period of benefit. Royalties are recognized as revenue when the customer's underlying sales occur. The transaction price and timing of revenue recognition are adjusted as necessary to reflect changes in expectations.

The Company may receive payments at the onset of the contract before delivery of goods for customers in the retail channel. Payment terms for distributors and original equipment manufacturers ("OEMs") are typically due within 30-90 days after shipment. In such instances, the Company records a customer deposit liability. The Company recognizes these contract liabilities as sales after the revenue criteria are met. As of June 30, 2025 and December 31, 2024, the contract liability related to the Company's customer deposits were approximately $166 and $317, respectively.

The Company recognized $314 of the contract liability as of December 31, 2024 during the six months ended June 30, 2025. During the six months ended June 30, 2024, the Company recognized $153 of the contract liability that was recorded as a January 1, 2024 beginning balance.

On July 29, 2024, Dragonfly Energy Corp. ("Legacy Dragonfly"), a wholly-owned subsidiary of the Company, and Battle Born Battery Products, LLC ("Battle Born LLC"), a wholly-owned subsidiary of Legacy Dragonfly, entered into a License Agreement (the "License Agreement") with Stryten Energy LLC ("Stryten") (**Note 7**). The $5,000 initial licensing fee is being recognized as revenue on a straight-line basis over five years. The Company has recorded $250 and $500 in revenue related to the license agreement for the three and six months ended June 30, 2025, respectively. As of June 30, 2025 and December 31, 2024, the contract liability related to the Company's deferred revenue were approximately $4,083 and $4,583, respectively. As of June 30, 2025, the Company had $1,000 in short term deferred revenue and $3,083 in long-term deferred revenue related to the License Agreement.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Disaggregation of Revenue</u>*

 

The following table presents the Company's disaggregated revenues by distribution channel:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For the Three Months Ended | For the Three Months Ended | For the Six Months Ended | For the Six Months Ended |
|  | June 30, | June 30, | June 30, | June 30, |
| Sales | 2025 | 2024 | 2025 | 2024 |
| &nbsp;&nbsp;&nbsp;Direct to customer | 5948 | 6534 | 10963 | 11737 |
| &nbsp;&nbsp;&nbsp;Original equipment manufacture | 10050 | 6674 | 18141 | 13976 |
| &nbsp;&nbsp;&nbsp;License fee revenue | 250 | - | 500 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $16248 | $13208 | $29604 | $25713 |

---

*<u>Product Warranty</u>*

 

The Company offers assurance type warranties from 5 to 10 years on its products. The Company estimates the costs associated with the warranty obligation using historical data of warranty claims and costs incurred to satisfy those claims. The Company estimates, based upon a review of historical warranty claim experience, the costs that may be incurred under its warranties and record a liability in the amount of such estimate at the time a product is sold. Factors that affect the Company's warranty liability include the number of units sold, historical and anticipated rates of warranty claims, and cost per claim. The Company periodically assesses the adequacy of its recorded warranty liability and adjust the accrual as claims data and historical experience warrants. The Company has assessed the costs of fulfilling its existing assurance type warranties and has determined that the estimated outstanding warranty obligation at June 30, 2025 and December 31, 2024 to be $695 and $514, respectively. The Company incurred warranty expense of $148 and $271 for the three and six months ended June 30, 2025, respectively, and incurred warranty expense of $99 and $301 for the three and six months ended June 30, 2024, respectively.

SCHEDULE OF WARRANTY OBLIGATION

---

| | |
|:---|:---|
|  | June 30,<br>2025 |
| Beginning warranty obligation | 514 |
| Provision of warranty expense | 271 |
| Settlement of warranty claims | (90) |
| &nbsp;&nbsp;&nbsp;Ending warranty obligation | $695 |

---

*<u>Concentrations</u>*

 

As of June 30, 2025, receivables from Customer A, Customer B, and Customer C comprised approximately 27%, 10%, and 10%, respectively, of accounts receivable. As of December 31, 2024, receivables from Customer A and B comprised approximately 15% and 21%, respectively, of accounts receivable. There are no other significant accounts receivable concentration.

For the six months ended June 30, 2025, sales from Customer A comprised approximately 26% of the Company's total revenue. For the six months ended June 30, 2024, sales from Customer A comprised approximately 14% of the Company's total revenue. For the three months ended June 30, 2025, sales from Customer A comprised approximately 32% of the Company's total revenue. For the three months ended June 30, 2024, sales from Customer A comprised approximately 12% of the Company's total revenue.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Concentrations (Continued)</u>*

 

As of June 30, 2025, payables to Vendor A, Vendor B, and Vendor C comprised approximately 28%, 20%, and 10%, respectively, of accounts payables. As of December 31, 2024, payables to Vendor A, Vendor C, and Vendor D comprised approximately 33%, 11%, and 12%, respectively, of accounts payables.

For the six months ended June 30, 2025, Vendor A accounted for approximately 16% of the Company's total purchases. For the six months ended June 30, 2024, there were no purchase concentrations present. For the three months ended June 30, 2025, Vendor A and Vendor B accounted for approximately 11% and 14% of the Company's total purchases. For the three months ended June 30, 2024, Vendor C accounted for approximately 15% of the Company's total purchases.

*<u>Stock-Based Compensation</u>*

 

The Company accounts for stock based compensation arrangements with employees and non-employee consultants using a fair value method which requires the recognition of compensation expense for costs related to all stock based payments, including stock options (**Note 12**). The fair value method requires the Company to estimate the fair value of stock based payment awards to employees and non-employees on the date of grant using an option pricing model. Stock based compensation costs are based on the fair value of the underlying option calculated using the Black Scholes option pricing model and recognized as expense on a straight line basis over the requisite service period, which is the vesting period. Restricted stock unit awards are valued based on the closing trading value of the Company's common stock on the date of grant and then amortized on a straight-line basis over the requisite service period of the award. The Company measures equity-based compensation awards granted to non-employees at fair value as the awards vest and recognizes the resulting value as compensation expense at each financial reporting period.

Determining the appropriate fair value model and related assumptions requires judgment, including estimating stock price volatility, expected dividend yield, expected term, risk free rate of return, and the estimated fair value of the underlying common stock. Due to the lack of company specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar companies that are publicly traded. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The group of representative companies have characteristics similar to the Company, including stage of product development and focus on the lithium ion battery industry. The Company uses the simplified method, which is the average of the final vesting tranche date and the contractual term, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The risk free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The Company uses an assumed dividend yield of zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock. The Company accounts for forfeitures as they occur.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Income Taxes</u>*

 

Deferred income tax assets and liabilities are determined based on the estimated future tax effects of net operating loss, credit carryforwards and temporary differences between the tax basis of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates.

The Company recognizes a tax benefit for an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The Company had a liability of $55 and $55 as of June 30, 2025 and December 31, 2024, respectively, of uncertain tax positions.

The Company's accounting policy is to include penalties and interest related to income taxes if any, in selling, general and administrative expenses. The Company regularly assesses the need to record a valuation allowance against net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

*<u>Net Loss per Common Share</u>*

 

Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted net loss earnings per share is calculated using the weighted-average number of common shares outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock.

The weighted-average number of common shares included in the computation of diluted net loss gives effect to all potentially dilutive common equivalent shares, including outstanding stock options and warrants.

Common stock equivalent shares are excluded from the computation of diluted net loss per share if their effect is antidilutive. In periods in which the Company reports a net loss, diluted net loss per share is generally the same as basic net loss per share since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.

The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive:

---

| | | |
|:---|:---|:---|
|  | June 30, | June 30, |
|  | 2025 | 2024 |
| Warrants | 4256156 | 3240917 |
| Restricted stock units | 195878 | 11778 |
| Preferred Shares Conversion\*\*\* | 2317840 |  |
| Options | 158247 | 212091 |
| Weighted average number of common shares-basic | 6928121 | 3464786 |

---

\*\*\* See footnote 10 for further details.

*<u>Leases</u>*

 

At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement including the use of an identified asset(s) and the Company's control over the use of that identified asset. The Company elected, as allowed under FASB ASU 2016-02, Leases ("ASC 842"), to not recognize leases with a lease term of one year or less on its balance sheet. Leases with a term greater than one year are recognized on the balance sheet as right-of-use ("ROU") assets and current and non-current lease liabilities, as applicable.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 2 – Summary of Significant Accounting Policies (continued)**

*<u>Segment Reporting</u>*

 

Operating segments are identified (**Note 14**) as components of an enterprise for which separate discrete financial information is available for evaluation by the Company's Chief Executive Officer to make decisions with respect to resource allocation and assessment of performance. Previously, the Company recognized one operating segment. Historically, the Company reported a single operating and reportable segment, as management evaluated the business on a consolidated basis. During the fourth quarter of 2024, the Company reassessed its internal reporting structure and how management monitors operations and makes decisions. As a result of this reassessment, the Company determined that it now manages its business through two distinct operating segments. This change was driven by the development of the Company's operations and internal decision-making processes, including the introduction of separate performance metrics and discrete financial information for each segment.

*<u>Recently issued accounting pronouncements</u>:*

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. The Company adopted ASU 2023-09 as of January 1, 2025.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires a public entity to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis. It is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. In January 2025, the FASB issued ASU 2025-01 to clarify that all public entities, including non-calendar year-end entities, should adopt the disclosure requirements of ASU 2024-03. The Company is currently evaluating the impact.

**Note 3 - Fair Value Measurements**

ASC 820, Fair Value Measurements and Disclosures ("ASC 820"), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company's own assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances.

ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes between the following:

● Level
 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.

● Level
 2 inputs are inputs other than quoted prices included within Level 1 that are observable for a similar asset or liability, either directly
 or indirectly.

● Level
 3 inputs are unobservable inputs that reflect the Company's own assumptions about the inputs that market participants would use
 in pricing the asset or liability.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 3 - Fair Value Measurements (continued)**

Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheets on a recurring basis as of June 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Carrying Amount | <br>Fair Value  | <br>(Level 1)  | <br>(Level 2)  | <br>(Level 3)  |
|  | As of June 30, 2025 | As of June 30, 2025 | As of June 30, 2025 | As of June 30, 2025 | As of June 30, 2025 |
| Liabilities |  |  |  |  |  |
| Warrant liability- Term Loan | $273 | $273 | $- | $273 | $- |
| Warrant liability- June Public Offering | 49 | 49 |  | 49 |  |
| Total liabilities | $322 | $322 | $- | $322 | $- |

---

The following table presents assets and liabilities that were measured at fair value in the Consolidated Balance Sheets on a recurring basis as of December 31, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Carrying Amount | <br>Fair Value  | <br>(Level 1)  | <br>(Level 2)  | <br>(Level 3)  |
|  | As of December 31, 2024 | As of December 31, 2024 | As of December 31, 2024 | As of December 31, 2024 | As of December 31, 2024 |
| Liabilities |  |  |  |  |  |
| Warrant liability- Term Loan | $3883 | $3883 | $- | $3883 | $- |
| Warrant liability- June Public Offering | 1250 | 1250 |  | 1250 |  |
| Total liabilities | $5133 | $5133 | $- | $5133 | $- |

---

Due to Black Scholes calculation being utilized on all fair value measurement of warrant liabilities as of June 30, 2025 and December 31, 2024, the fair value warrant liabilities were transferred from Level 3 to Level 2 as of December 31, 2024. This is due to the observable inputs (such as the Company's stock price and comparable company volatility calculations) included in the Black Scholes calculation, which makes the fair value measurement of the warrant liabilities more closely aligned with Level 2.

The carrying amounts of accounts receivable and accounts payable are considered Level 1 and approximate fair value as of June 30, 2025 and December 31, 2024 because of the relatively short maturity of these instruments.

The carrying value of the term loan as of June 30, 2025 and December 31, 2024 approximates fair value as the interest rate does not differ significantly from the current market rates available to the Company for similar debt and is considered Level 2.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 3 - Fair Value Measurements (continued)**

**Level 3 Roll forward**

Fair value measurements categorized within Level 3 are sensitive to changes in assumptions or methodology used to determine fair value, and such changes could result in a significant increase or decrease in the fair value.

The changes for Level 3 items measured at fair value on recurring basis using significant unobservable inputs are as follows:

There was no Level 3 activity for the three and six months ended June 30, 2025.

---

| | | |
|:---|:---|:---|
|  | Warrant Liability - Term Loan | Warrant liability- June Public Offering |
| **Fair value as of January 1, 2024** | $1014 | $3434 |
| Change in fair value, gain included in net loss<sup>(1)</sup> | (4) | (220) |
| **Fair value as of March 31, 2024** | 1010 | 3214 |
| Warrants Issued | 4796 |  |
| Change in fair value, gain included in net loss<sup>(1)</sup> | (304) | 2277 |
| **Fair value as of June 30, 2024** | $5502 | $5491 |

---

<sup>(1)</sup> *Changes in fair value of warrant liabilities are disclosed separately in the Consolidated Statements of Operations*

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 4 - Inventory**

Inventory consists of the following:

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | December 31, 2024 |
| Raw material | $18298 | $18776 |
| Finished goods | 2755 | 2940 |
| Total inventory | $21053 | $21716 |

---

**Note 5 - Commitments and Contingencies**

*Litigation*

 

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings, governmental actions, administrative actions, investigations or claims are pending against the Company or involve the Company that, in the opinion of the Company's management, could reasonably be expected to have a material adverse effect on the Company's business and financial condition.

*Operating Leases*

 

The Company has leases related to the main office, warehouse space, research and development lab, engineering office, and sales office, all located in Reno, Nevada. The leases require annual escalating monthly payments ranging from $111 to $309. On February 2, 2022, the Company entered into a 124-month lease agreement in Reno, Nevada. The lease calls for monthly base rent of $230, $23 of fixed operating expense costs, and estimated monthly property taxes of $21. The monthly base rent and fixed operating expense costs are subject to escalation of 3% and 2.4%, respectively, on an annual basis. A certificate of substantial completion has been issued and the lease commencement date was March 25, 2024. The Company began paying monthly rent under the lease on July 24, 2024.

On April 12, 2024 the Company entered into a lease agreement, pursuant to which the Company agreed to lease an approximately 64,000 square foot facility (the "Premises") located in Fernley, Nevada, to be used for general, warehousing, assembly/light manufacturing, painting of products, storage fulfillment, distribution of the Company's products, and other uses as permitted under the Fernley Lease Agreement (the "Fernley Lease Agreement"). The effective date of the lease is April 1, 2024 (the "Lease Commencement Date"). However, the initial term of the Fernley Lease Agreement (the "Term") is for a period of sixty (60) months, effective June 1, 2024 (the "Rent Commencement Date"). The base rent for the Premises, payable monthly, was $45 for the first ten months, starting June 1, 2024, and is subject to a three percent (3.0%) increase on the anniversary of the Lease Commencement Date each year. The Company also will be responsible for twenty-five percent (25%) of any operating expenses, taxes and insurance expenses incurred by the Landlord in connection with the building in which the Premises are located (the "Expenses") as well as utility expenses. The Expenses are subject to recalculation and increase upon the completion of the Initial Improvements (as defined in the Fernley Lease Agreement). The Landlord is responsible for completing the Initial Improvements. The Fernley Lease Agreement also contains customary default provisions allowing the Landlord to terminate the Fernley Lease Agreement if the Company fails to cure certain breaches of its obligations under the Fernley Lease Agreement within a specified period of time upon written notice to the Company. Concurrent with the execution of the Fernley Lease Agreement, the Company paid the Landlord a security deposit of $50.

On May 8, 2025, the Company entered into a sixth lease amendment with its landlord to extend the lease term for an additional sixty-four (64) month period for the research and development lab and engineering office in Reno, Nevada. Under the terms of the amended lease, the base rent due shall be fully abated for the four (4) month period commencing on August 1, 2025, and ending on November 30, 2025. The lease is set to expire on November 30, 2030.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 5 - Commitments and Contingencies (continued)**

The following table presents the breakout of the operating leases as of:

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | December 31, 2024 |
| Operating lease right-of-use assets | $19055 | $19737 |
| Short-term operating lease liabilities | 2949 | 2926 |
| Long-term operating lease liabilities | 21771 | 22588 |
| Total operating lease liabilities | $24720 | $25514 |
| Weighted average remaining lease term | 8.09 years | 8.46 years |
| Weighted average discount rate | 7.91% | 7.86% |

---

Assumptions used in determining the Company's incremental borrowing rate include its implied credit rating and an estimate of secured borrowing rates based on comparable market data.

At June 30, 2025, the future minimum lease payments under these operating leases are as follows:

---

| | |
|:---|:---|
| Fiscal Years Ending |  |
| December 31, 2025<sup>(1)</sup> | 2412 |
| December 31, 2026 | 4528 |
| December 31, 2027 | 3746 |
| December 31, 2028 | 3860 |
| December 31, 2029 | 3614 |
| Thereafter | 16046 |
| Total lease payments | 34206 |
| Less imputed interest | 9486 |
| Total operating lease liabilities | $24720 |

---

<sup>(1)</sup> Represents scheduled payments for the remaining six-month period ending December 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | For The Three Months<br> Ended June 30, | For The Three Months<br> Ended June 30, | For The Six Months<br> Ended June 30, | For The Six Months<br> Ended June 30, |
| Lease cost | Classification | 2025 | 2024 | 2025 | 2024 |
| Operating lease cost | Cost of goods sold | $610 | $341 | $1237 | $691 |
| Operating lease cost | Research and development | 37 | 130 | 77 | 153 |
| Operating lease cost | General and administration | 724 | 762 | 1541 | 1032 |
| Operating lease cost | Selling and marketing | 13 | 11 | 26 | 23 |
| Total lease cost |  | $1384 | $1244 | $2881 | $1899 |

---

All lease costs included in the schedule above are fixed.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 5 - Commitments and Contingencies (continued)**

*Financing Leases*

 

The Company entered into finance lease agreements for equipment to support the Company's operations. Payments under the finance lease agreements are fixed for a term of 3-5 years. The leased assets are recognized in property plant & equipment.

The following table presents the breakout of the financing leases as of:

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | December 31, 2024 |
| Finance lease right-of-use assets | $103 | $121 |
| Short-term finance lease liabilities | 48 | 47 |
| Long-term finance lease liabilities | 39 | 63 |
| Total finance lease liabilities | $87 | $110 |
| Weighted average remaining lease term | 2.41 years | 2.78 years |
| Weighted average discount rate | 5.2% | 5.2% |

---

Assumptions used in determining the Company's incremental borrowing rate include its implied credit rating and an estimate of secured borrowing rates based on comparable market data.

At June 30, 2025, the future minimum lease payments under these financing leases are as follows:

---

| | |
|:---|:---|
| Fiscal Years Ending |  |
| December 31, 2025<sup>(1)</sup> | 26 |
| December 31, 2026 | 37 |
| December 31, 2027 | 18 |
| December 31, 2028 | 9 |
| December 31, 2029 | 2 |
| Total lease payments | 92 |
| Less imputed interest | 5 |
| Total financing lease liabilities | $87 |

---

<sup>(1)</sup> Represents scheduled payments for the remaining six-month period ending December 31, 2025.

*Other Contingencies*

In March 2025, the Company agreed to pay LithiumHub a total of $2.5 million, of which $0.6 million is payable in 2025 and approximately $1.9 million is payable in 2026, in exchange for a non-exclusive license in LithiumHub Technologies, LLC's patent rights related to the Patents-in-Suit. In accordance with the Settlement Agreement, the Company and LithiumHub terminated the ongoing patent litigation between them. The Settlement Agreement includes no admission of infringement by the Company. As of June 30, 2025, the balance of the accrued settlement liability is $2.3 million, of which $1.4 million is classified as current and $0.9 million as non-current.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 6 - Long Term Debt**

**<u>Term Loan Agreement</u>**

As of June 30, 2025, the Company had an outstanding term loan under a Term Loan, Guarantee and Security Agreement (the "Term Loan Agreement"), dated October 7, 2022, with EICF Agent LLC, as agent, and certain lenders. The Term Loan matures on October 7, 2027 and amortizes at a rate of 5% per annum beginning in October 2024.

Prior to any amendments, the Term Loan accrues interest based on the Company's senior leverage ratio. From inception through September 30, 2024, interest accrued at a per annum rate equal to adjusted SOFR (subject to a floor of 1.0%) plus 7.0% payable in cash, plus an additional 4.5% to 6.5% payable in kind ("PIK"), depending on the Company's senior leverage ratio. Effective April 1, 2024, interest payable to lenders subject to the regulations of the U.S. Small Business Administration (with $30,846 of principal outstanding as of that date) is limited to 14.0% per annum, excluding default interest permitted under applicable SBA regulations. From October 1, 2024 through March 31, 2025, interest on the non-SBA regulated portion continued to accrue at adjusted SOFR plus 7.0% payable in cash, and 4.5% to 6.5% payable in kind. Beginning April 1, 2025, interest on all outstanding balances will be payable entirely in cash, at a rate equal to adjusted SOFR plus a margin ranging from 11.5% to 13.5%, depending on the Company's senior leverage ratio.

During the six months ended June 30, 2025 and 2024, the Company recognized interest expense of $7,307 and $7,022, respectively. During the three months ended June 30, 2025 and 2024, the Company recognized interest expense of $3,728 and $3,321, respectively. Amortization of the debt issuance costs amounted to $2,784 and $2,428, respectively, during the six months ended June 30, 2025 and 2024. Amortization of the debt issuance costs amounted to $1,689 and $1,534, respectively, during the three months ended June 30, 2025 and 2024. As of December 31, 2024, the carrying value was $29,646, consisting of $69,974 in principal, plus $15,938 in capitalized PIK interest, net of $56,266 in unamortized debt discount.

The obligations under the Term Loan Agreement are secured by a first-priority lien on substantially all of the Company's assets, including certain mortgaged properties.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 6 - Long Term Debt (continued)**

*Financial Covenants*

 

The Company is subject to restrictive financial covenants pertaining to Maximum Senior Leverage Ratio, Liquidity, Fixed Charge Coverage Ratio, and Capital Expenditures as defined in the Term Loan Agreement. As of December 31, 2024, the Company was not in compliance with its financial covenants pertaining to the fixed charge coverage ratio, liquidity, and the maximum senior leverage ratio. On March 31, 2024, April 29, 2024, May 30, 2024, June 28, 2024, July 31, 2024, August 30, 2024, September 30, 2024, October 31, 2024, November 30, 2024 and December 31, 2024 the Company obtained waivers from the Term Loan Lenders and administrative agent in regards to its failure to satisfy the liquidity requirement under the Term Loan for the quarters ended March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024 and the fiscal months ended April 30, 2024, May 31, 2024, July 31, 2024, August 31, 2024, October 31, 2024 and November 30, 2024, as applicable.

In February 2025, in connection with the Purchase Agreement, the Company entered into the Fifth Amendment to the Term Loan. This amendment extended the loan's maturity date by one year to October 2027 and deferred all principal and interest payments until April 2026. Additionally, the amendment postponed certain covenant requirements, significantly reducing the likelihood of a breach and the lender's ability to accelerate repayment based on prior noncompliance, thereby allowing the Company to reclassify the debt as long-term as of December 31, 2024.

At June 30, 2025 the future debt maturities are as follows:

---

| | |
|:---|:---|
| For Year Ended December 31, |  |
| 2025 |  |
| 2026 | 2813 |
| 2027 | 98429 |
| Total debt | 101242 |
| Less: Estimated interest paid-in-kind | (8023) |
| Total debt | 93219 |
| Less: Unamortized debt discount costs | (54179) |
| Total carrying amount | 39040 |
| Less: Current portion of debt | (393) |
| Total long-term debt | $38647 |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 7 - License Agreement**

On July 29, 2024, Legacy Dragonfly and Battle Born LLC, a wholly-owned subsidiary of Legacy Dragonfly, entered into the License Agreement with Stryten. Under the terms of the License Agreement, Battle Born LLC granted Stryten an exclusive, worldwide license to use certain trademarks associated with the Company's lithium-ion battery brand, Battle Born Batteries®, for business-to-business battery sales in specified markets. In exchange, Stryten paid an initial licensing fee of $5,000 and will make additional mid-single digit royalty payments to be paid based on net sales to be paid quarterly utilizing the licensed trademarks, with total royalties capped at $25,000. Once the cap is reached, Stryten will be required to pay a nominal annual license fee. The License Agreement is perpetual unless terminated in accordance with its terms. Concurrently, the Company transferred all intellectual property rights related to the licensed trademarks to Battle Born LLC and retained a worldwide license outside of Stryten's designated markets. The $5,000 initial licensing fee is being recognized as revenue on a straight-line basis over five years. For the three months and six ended June 30, 2025, the Company has recorded $250 and $500 in revenue related to the amortization of the License Agreement and no royalty payments have been received or earned. As of June 30, 2025, the Company has recorded $1,000 in short term deferred revenue and $3,083 in long-term deferred revenue related to the license agreement. As of December 31, 2024, the Company has recorded $1,000 in short term deferred revenue and $3,583 in long-term deferred revenue related to the license agreement.

**Note 8 - Related Party**

On January 26, 2024 the Company entered into a convertible promissory note (the "January Note") with a board member in the amount of $1,000, or the January Principal Amount. Upon execution of the January Note and funding of the original principal sum, a payment of $50 (the "January Loan Fee") was fully earned as of the date of the January Note and was due and payable in full in cash on February 2, 2024. The Company paid the January Principal Amount and the January Loan Fee on February 1, 2024.

On February 27, 2024 the Company entered into a convertible promissory note (the "February Note") with a board member in the amount of $1,700, or the February Principal Amount. Upon execution of the February Note and funding of the original principal sum, a payment of $85 (the "February Loan Fee") was fully earned as of the date of the February Note and was due and payable in full in cash on March 1, 2024. The Company paid the February Principal Amount and the February Loan Fee on March 1, 2024.

Effective April 12, 2024, the Company entered into amendments to the employment agreements with its Chief Executive Officer, its Chief Revenue Officer and its Chief Marketing Officer to amend the terms of their annual equity compensation (the "Amended Employee Agreements"). The Amended Employee Agreements allow the Company to issue a combination of cash and equity awards on an annual basis up to a specified amount ($1,532 for the Chief Executive Officer, $490 for the Chief Revenue Officer and $236 for the Chief Marketing Officer), subject to approval and such other terms and conditions imposed by the compensation committee of the board of directors.

On February 1, 2025, the Company appointed Dr. Vickram Singh, the Company's former Senior Vice President of Technology, as its Chief Operating Officer pursuant to an employment agreement, dated February 1, 2025 (the "Employment Agreement"). Dr. Singh's employment as the Company's Chief Operating Officer commenced on February 4, 2025. The Employment Agreement provides for a three-year initial employment term, with automatic three-year renewal terms thereafter, subject to 90 days' notice of nonrenewal by either party. The Employment Agreement also provides for an initial annual base salary of $350,000 (the "Base Salary") and a discretionary annual bonus of up to 65% of the Base Salary.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 9 - Warrants**

**Common Stock Warrants classified as Equity**

*Public Warrants*

 

The Company's Public Warrants are classified as equity and as of June 30, 2025 and December 31, 2024, there were 1,046,948 Public Warrants issued and outstanding.

During the three and six months ended June 30, 2025 and 2024, no public warrants were exercised.

*June 2023 Offering (Underwriter and Investor Warrants)*

 

In connection with the entry into the underwriting agreement as further described in Note 11 of the financial statements, (the "June 2023 Offering") the Company issued (i) underwriters warrants to purchase up to an aggregate of 63,362 shares of common stock (the "Underwriters' Warrants") which are exercisable upon issuance and will expire on June 20, 2028. The initial exercise price of the Underwriters' Warrants is $22.50 per share, which equals 125% of the per share public offering price in the June 2023 Offering and (ii) warrants to purchase up to 1,111,111 shares of common stock to the investors in the offering together with shares of common stock (the "Investor Warrants"), at the combined public offering price of $18.00 per share of common stock and accompanying Investor Warrant, less underwriting discounts and commissions.

 

The Company also granted the underwriters a 45-day over-allotment option to purchase up to an additional 166,667 shares of common stock and/or Investor Warrants to purchase up to 166,667 shares of common stock at the public offering price per security, less underwriting discounts and commissions. The underwriters exercised their over-allotment option to purchase an additional 156,112 shares of common stock and Investor Warrants to purchase up to 156,112 shares of common stock. The Company accounts for the Investor Warrants issued in connection with the Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the Investor Warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liabilities will be adjusted to its current fair value, with the change in fair value recognized in the Company's statement of operations. The Company will reassess the classification at each balance sheet date. It was determined that the Underwriters' Warrants were not precluded from equity treatment and have been accounted for as such.

Underwriters' Warrants:

---

| | | |
|:---|:---|:---|
|  | Common Stock Warrants | Common Stock Warrants |
| Underwriters' Warrants Outstanding, January 1, 2025 |  | 63362 |
| Underwriters' Warrants issued | | - |
| Underwriters' Warrants Outstanding, June 30, 2025 | | 63,362 |

---

**Common Stock Warrants classified as Liability**

*Private Placement Warrants*

 

There were 166,821 private warrants (the "Private Placement Warrants") outstanding as of June 30, 2025 and December 31, 2024, respectively. The Company accounts for the Private Placement Warrants issued in connection with the Initial Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the private warrants do not meet the criteria for equity treatment thereunder, each private warrant must be recorded as a liability. This liability is subject to re-measurement at each balance sheet date.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 9 - Warrants (Continued)**

**Common Stock Warrants classified as Liability (Continued)**

*Private Placement Warrants (Continued)*

 

With each such re-measurement, the warrant liabilities will be adjusted to its current fair value, with the change in fair value recognized in the Company's statement of operations. The Company will reassess the classification at each balance sheet date.

The Private Placement Warrants are classified as Level 2 within the fair value hierarchy. Although these instruments are not actively traded, they are valued based on observable inputs, including the market price of the Company's publicly traded warrants. The Company used a Black-Scholes model to estimate the fair value of the Private Placement Warrants, applying a discount to the value of the Public Warrants to account for the difference in remaining life. Because the valuation primarily relies on observable market data with limited adjustments, the Company determined that classification within Level 2 is appropriate.

*Term Loan Warrants*

 

On May 13, 2024, the Company received a waiver, or the May 2024 Waiver, in regards to its compliance with the fixed charge coverage ratio and maximum senior leverage ratio with respect to the minimum cash requirements (the "Tests") as of the last day of the quarter ended March 31, 2024. The May 2024 Waiver provided for a one-time issuance of the May 2024 Penny Warrants to purchase up to 283,334 shares of the Company's common stock, at an exercise price of $0.09 per share, in connection with the Term Loan Lenders' agreement to waive the Tests under the Term Loan for the quarter ended March 31, 2024. The May 2024 Penny Warrants were immediately exercisable upon issuance and will expire ten years from the date of issuance.

On June 28, 2024, the Company entered into the First Amendment to the Term Loan with the Term Loan Lenders in regards to its compliance with the Tests for the quarter ended June 30, 2024. The First Amendment provided for a one-time issuance of the June 2024 Penny Warrants to purchase up to 233,334 shares of the Company's common stock, at an exercise price of $0.09 per share, in connection with the Term Loan Lenders' agreement to waive the Tests under the Term Loan for the quarter ended June 30, 2024 and certain amendments to the Term Loan. The June 2024 Penny Warrants are immediately exercisable upon issuance and will expire ten years from the date of issuance.

On September 30, 2024, the Company entered into the Third Amendment to the Term Loan with the Term Loan Lenders in regards to its compliance with the Tests for the quarter ended September 30, 2024. The Third Amendment provided for a one-time issuance the September 2024 Penny Warrants to purchase up to 333,334 shares of the Company's common stock, at an exercise price of $0.09 per share, in connection with the Term Loan Lenders agreement to waive the Tests under the Term Loan for the quarter ended September 30, 2024 and to amend the Term Loan. The September 2024 Penny Warrants are immediately exercisable upon issuance and will expire ten years from the date of issuance.

On December 31, 2024, the Company entered into the Fourth Amendment to the Term Loan with the Term Loan Lenders in regards to its compliance with the Tests for the quarter ended December 31, 2024. The Fourth Amendment provided for a one-time issuance the December 2024 Penny Warrants to purchase up to 350,000 shares of the Company's common stock, at an exercise price of $0.01 per share, in connection with the Term Loan Lenders agreement to waive the Tests under the Term Loan for the quarter ended December 31, 2024 and to amend the Term Loan. During the year ended December 31, 2024 the Company issued additional Original Penny Warrants to purchase 2,754 shares of common stock to the Term Loan Lenders in accordance with the anti-dilution provisions of the original penny warrants with respect to certain sales made by the Company under the ChEF Equity Facility. The December 2024 Penny Warrants are immediately exercisable upon issuance and will expire ten years from the date of issuance.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 9 - Warrants (continued)**

**Common Stock Warrants classified as Liability (Continued)**

On February 26, 2025, the Company entered into the Fifth Amendment to the Term Loan with the Term Loan Lenders in connection with the February 2025 securities purchase agreement (see **Note 10**). The Fifth Amendment provided for a one-time issuance the February 2025 Penny Warrants to purchase up to 330,000 shares of the Company's common stock, at an exercise price of $0.01 per share. The February 2025 Penny Warrants are immediately exercisable upon issuance and will expire ten years from the date of issuance.

The May 2024 Penny Warrants, the June 2024 Penny Warrants, the September 2024 Penny Warrants, the December 2024 Penny Warrants and the February 2025 Penny Warrants (together, the "Penny Warrants") were valued utilizing a Black-Scholes model with the following assumptions:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | May 2024 penny warrants | June 2024 penny warrants | September 2024 penny warrants | December 2024 penny warrants | February 2025 penny warrants |
| Stock price | $10.71 | $7.65 | $4.77 | $2.78 | $2.12 |
| Strike price | $0.09 | $0.09 | $0.09 | $0.01 | $0.01 |
| Term | 10 years | 10 years | 10 years | 10 years | 10 years |
| Volatility | 88% | 91% | 90% | 90% | 90% |
| Risk-free rate | 4.5% | 4.4% | 3.8% | 4.6% | 4.3% |

---

The Company concluded the Penny Warrants are not considered indexed to the Company's common stock and to be accounted for as liabilities under ASC 815. As such, the estimated fair value is recognized as a liability each reporting period, with changes in the fair value recognized within income each period. There were no Penny Warrants outstanding prior to the merger.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 9 - Warrants (continued)**

**Common Stock Warrants classified as Liability (Continued)**

The following table provides the significant inputs to the Black-Scholes method for the fair value of the Penny Warrants:

---

| | | |
|:---|:---|:---|
|  | As of <br>June 30, 2025 | As of <br>December 31, 2024 |
| Common stock price | $0.16 | $2.78 |
| Exercise price | $0.09 | $0.09 |
| Dividend yield | 0% | 0% |
| Term | 7.27 | 7.77 |
| Volatility | 116.00% | 94.00% |
| Risk-free rate | 4.0% | 4.5% |
| Fair value | $0.15 | $2.74 |

---

The following table provides the significant inputs to the Black-Scholes method for the fair value of the Investor Warrants issued in the June 2023 Offering:

---

| | | |
|:---|:---|:---|
|  | As of <br>June 30, 2025 | As of <br>December 31, 2024 |
| Common stock price | $0.16 | $2.78 |
| Exercise price | $18.00 | $18.00 |
| Dividend yield | 0% | 0% |
| Term | 2.98 | 3.47 |
| Volatility | 155% | 105% |
| Risk-free rate | 3.7% | 4.3% |
| Fair value | $0.04 | $1.01 |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 9 - Warrants (continued)**

**Common Stock Warrants classified as Liability (Continued)**

The following table presents a roll-forward of the Company's warrants from January 1, 2025 to June 30, 2025 and January 1, 2024 to June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Private Warrants | Public <br>Warrants | Term Loan <br>Warrants | Investor <br>Warrants |
| Warrants Outstanding, January 1, 2025 | 166821 | 1046948 | 1412147 | 1236878 |
| Exercise of warrants |  |  |  |  |
| Warrants issued | - | - | 330000 | - |
| Warrants Outstanding, June 30, 2025 | 166821 | 1046948 | 1742147 | 1236878 |
| Warrants Outstanding, January 1, 2024 | 166821 | 1046948 | 209391 | 1236878 |
| Exercise of warrants |  |  |  |  |
| Warrants issued | - | - | 517519 | - |
| Warrants Outstanding, June 30, 2024 | 166821 | 1046948 | 726910 | 1236878 |

---

 

**Private Placement Convertible Preferred Warrants classified as Liability**

In February 2025, in connection with a private placement offering of Series A Preferred Stock (see **Note 10**), the Company issued 20 Private Placement Convertible Preferred Warrants (as defined below). Each warrant entitles the holder to purchase up to 200 shares of Series A Preferred Stock at an exercise price of $10,000 per share. The warrants are exercisable immediately and expire upon the earliest of: (i) 33 months after the shares of common stock issuable upon conversion of Series A Preferred Stock are registered for resale under the Securities Act, (ii) the occurrence of a Change of Control (as defined in the Certificate of Designation), or (iii) the full redemption of Series A Preferred Stock. The number of underlying shares and the exercise price are subject to adjustment in the event of stock splits, combinations, dividends, reclassifications, or other similar events. Upon exercise of the warrants, the Series A Preferred Stock is convertible into common stock at a conversion price that is subject to a floor of $0.424 per share, pursuant to the terms set forth in the Certificate of Designation.

The Company accounts for the Private Placement Convertible Preferred Warrants issued in connection with the initial offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the Private Placement Convertible Preferred Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Convertible Preferred Warrant must be recorded as a derivative liability with the initial fair value of approximately $120. This liability is subject to re-measurement at each balance sheet date, with changes recorded in the consolidated statement of operations and comprehensive loss. However, the Company has deemed the fair value at inception as immaterial for initial recognition of the liability and will continue to monitor the change in fair value for subsequent periods. On June 23, 2025, the Company and the holder of the Private Placement Convertible Preferred Warrants agreed to cancel such holder's warrants to purchase up to an aggregate of 4,000 shares of Series A Preferred Stock, with an exercise price of $10,000 per share of Series A Preferred Stock. As a result, the Private Placement Convertible Preferred Warrants are no longer outstanding. Please see Note 10 for more information as related to the aforementioned initial closing of the Private Placement.

The following table presents a roll-forward of the Company's Private Placement Convertible Preferred Warrants from January 1, 2025 to June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
|  | Number of Warrants | Preferred Shares Underlying Warrants | Common Shares Underlying (at $1.00 floor) |
| Warrants Outstanding, January 1, 2025 |  |  |  |
| Exercise of warrants |  |  |  |
| Warrants issued | 20 | 4000 | 48000000 |
| Warrants Outstanding, March 31, 2025 | 20 | 4000 | 48000000 |
| Exercise of warrants |  |  |  |
| Warrants issued |  |  |  |
| Cancellation of warrants | (20) | (4000) | (48000000) |
| Warrants Outstanding, June 30, 2025 | - | - | - |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 10 - Redeemable Convertible Preferred Stock**

In February 2025, the Company entered into a securities purchase agreement (the "Purchase Agreement") with an institutional investor. Pursuant to the Purchase Agreement, the investor agreed to purchase in a registered direct offering (the "Registered Direct Offering") from the Company 180 shares of Series A Convertible Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock" or "Redeemable Convertible Preferred Stock"), at a price of $10,000 per share, initially convertible into shares of common stock of the Company, at a conversion price of $2.332 per share of common stock.

The Company conducted an initial offering (the "Initial Closing"), which included the sale of Series A Preferred Stock through a Registered Direct Offering (the "Registered Direct Offering") and a Private Placement pursuant to the Purchase Agreement (the "Private Placement"). In the Private Placement, the Company agreed to sell: (i) 170 additional shares of Series A Preferred Stock at the same price as in the Registered Direct Offering, with a conversion price of $2.332 per share, and (ii) 20 warrants (the "Private Placement Convertible Preferred Warrants") to purchase up to 4,000 shares of Series A Preferred Stock at $10,000 per share. The Floor Price for the Series A Preferred Stock sold in the Initial Closing was $0.424. These terms are subject to adjustments for corporate events like stock splits.

In total, the Company sold 350 shares of Series A Preferred Stock and 20 Private Placement Convertible Preferred Warrants, raising approximately $3.2 million in net proceeds, which will be used for working capital and other general purposes.

On April 28, 2025, the Company completed the second closing of the Private Placement (the "Second Closing") pursuant to the Purchase Agreement. In connection with the Second Closing, the investor purchased an additional 450 shares of Series A Preferred Stock at a price of $10,000 per share, resulting in net proceeds of $4.2 million, which the Company received during the second quarter of 2025.

The terms of the Series A Preferred Stock issued in the Second Closing were substantially similar to those issued in the Initial Closing, except that the initial conversion price was set at $0.594 per share, with a Floor Price of $0.10902 per share. The Second Closing shares are convertible into common stock at the option of the holder, subject to certain limitations and adjustments.

The Company filed a Certificate of Designation of the Powers, Preferences and Relative, Participating, Optional and Other Restrictions of Series A Convertible Preferred Stock of the Company (the "Certificate of Designation") with the Secretary of State of the State of Nevada to establish the rights, privileges, preferences, and restrictions of the Series A Preferred Stock. As set forth in the Certificate of Designation, the Company designated 5,000 shares of preferred stock as Series A Preferred Stock. The following is a summary of the principal terms of the Certificate of Designation:

*General.* Each share of Series A Preferred Stock has a stated value of $10,000 per share (the "Series A Stated Value") and, when issued, the Series A Preferred Stock will be fully paid and non-assessable.

*Ranking.* The Series A Preferred Stock ranks senior to all other Company capital stock for dividends, distributions, and liquidation payments, unless otherwise approved by the Required Holder (as defined in the Certificate of Designation).

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 10 - Redeemable Convertible Preferred Stock (Continued)**

*Dividends.* Series A Preferred Stock holders are entitled to receive 8% annual dividends, starting from issuance, payable quarterly in arrears in cash or additional Series A shares (defaulting to in-kind unless stated otherwise). If a Triggering Event (as defined in the Certificate of Designation) occurs, the rate increases to up to the lesser of 18% or maximum rate permitted under applicable law until resolved.

*Conversion at Option of Holder.* Holders may convert their Series A Preferred Stock into common stock at any time after issuance, subject to ownership limits and the issuable maximum, at a rate based on the Conversion Amount (as defined below), divided by the Conversion Price (as defined below), and subject to a Floor Price.

*Voluntary Adjustment Right.* Subject to the rules and regulations of Nasdaq, the Company has the right, at any time, with the written consent of the Required Holder, to lower the fixed conversion price to any amount and for any period of time deemed appropriate by the Company's board of directors.

*Alternate Conversion at the Holder's Election.* At the holder's option, at any time, the holder may convert (an "Alternate Conversion") some or all of such holder's Series A Preferred Stock, at a conversion price equal to the lower of (i) the applicable Conversion Price as in effect on the date of such Alternate Conversion, and (ii) the greater of (x) the Floor Price and (y) 90% of the lowest VWAP (as defined in the Certificate of Designation) of the common stock during the ten (10) consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice as set forth in the Certificate of Designation (the "Alternate Conversion Price").

With respect to each share of Series A Preferred Stock, as of the applicable date of determination, the "Conversion Amount" is equal to the sum of (1) 120% of (i) the Series A Stated Value plus (ii) all declared and unpaid dividends on such shares as of such date of determination plus (2) any other amounts thereon owed to such holder, pursuant to this Certificate of Designations or any other Transaction Document (as defined in the Certificate of Designation) that have not otherwise been paid or satisfied.

The Conversion Price varies depending on the issuance circumstances of the Series A Preferred Stock and is subject to adjustments. (i) for Series A Preferred Stocks issued in the Registered Direct Offering and at the initial closing of the Private Placement, the Conversion Price is fixed at $2.332 per share (the "Initial Conversion Price"); (ii) for Series A Preferred Stocks issued at the Second Closing or upon the exercise of a Private Placement Warrant (excluding cases under points (iii) and (iv) below), the Conversion Price is the lower of (x) the Initial Conversion Price and (y) 110% of the last closing trade price on the trading day before the Second Closing, relevant Funding Date, or Exercise Date (as defined in each Private Placement Warrant); (iii) if a Series A Preferred Stock is issued upon warrant exercise when certain equity conditions are not met, the Conversion Price is the lower of (A) $3.50 and (B) 110% of the closing price on the trading day before delivery of the Exercise or Call Notice; And (iv) if warrants are exercised after the Registration Effectiveness Date (as defined in the Certificate of Designation) and the common stock has traded above $10.00 for 20 consecutive trading days, and equity conditions are not met, the Conversion Price will be 110% of the closing price on the trading day before the Exercise or Call Notice. In all cases, the Conversion Price is subject to proportional adjustments in the event of stock splits, dividends, combinations, and/or similar corporate actions and as set forth below under "Other Adjustments" below.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 10 - Redeemable Convertible Preferred Stock (Continued)**

The Floor Price varies based on when and how the Series A Preferred Stock is issued: (i) for Series A Preferred Stocks sold in the Registered Direct Offering, the Floor Price is $1.00; (ii) for Series A Preferred Stocks sold at the initial closing of the Private Placement, it is $0.424, which represents 20% of the Nasdaq Minimum Price of the common stock on the trading day before the Purchase Agreement was signed; (iii) for Series A Preferred Stocks issued after the initial closing—including those in the Second Closing—the Floor Price is 20% of the Nasdaq Minimum Price as of the trading day immediately before issuance. If, after six months from the initial issuance date, the current Floor Price exceeds the Adjusted Floor Price (as defined in the Certificate of Designation), the Required Holder may elect to lower the Floor Price to the Adjusted Floor Price, subject to Nasdaq approval. Both the Floor Price and Adjusted Floor Price are subject to proportional adjustments for stock splits, dividends, combinations, and/or similar corporate events.

*Other Adjustments.* Until stockholder approval is obtained, the Company may not issue more than 1,450,489 shares of common stock upon conversion of the Series A Preferred Stock and in certain related transactions—an amount equal to 19.99% of the total outstanding shares as of February 26, 2025—subject to adjustments for stock splits, recapitalizations, and similar events (the "Issuable Maximum"). This limit applies collectively to all conversions of Series A Preferred Stock and related securities. Additionally, if the Company issues common stock at a price lower than the then-current Conversion Price (the "New Issuance Price"), the Conversion Price will be adjusted downward to the New Issuance Price.

*Purchase Rights.* If the Company issues options, convertible securities, or other purchase rights to acquire stock or property to all or most holders of common stock ("Purchase Rights"), holders of Series A Preferred Stock will also be entitled to receive these rights. Each holder may acquire the same Purchase Rights as if they had already converted all of their Series A Preferred Stock into common stock at the Alternate Conversion Price, subject to the Beneficial Ownership Limitation.

*Liquidation Preference.* Each share of Series A Preferred Stock carries a liquidation preference equal to the greater of (A) the conversion of such Series A Preferred Stock on the date of such payment and (B) the amount per share such holder would receive if such holder converted such Series A Preferred Stock into common stock immediately prior to the date of such payment.

*Mandatory Redemption Triggering Event.* Upon any Mandatory Triggering Event (as defined in the Certificate of Designation), the Company shall immediately redeem in cash all amounts due under the Series A Preferred Stock at a redemption price equal to the Conversion Amount to be redeemed.

*Voting Rights.* Holders of Series A Preferred Stock have no voting power, cannot vote on any matters, and cannot call or participate in shareholder meetings, except as outlined in the Certificate of Designation or required by law. The Company cannot take certain actions without the prior consent of the Required Holder, including: (a) altering the powers, preferences, or rights of the Series A Preferred Stock or amending the Certificate of Designation, (b) creating any stock class senior or pari passu to the Series A Preferred Stock, (c) amending the articles of incorporation in ways that negatively affect the Series A Preferred Stock rights, (d) changing the number of authorized Series A Preferred Stock, (e) paying dividends or making distributions on common stock, (f) purchasing or redeeming junior capital stock, (g) issuing Series A Preferred Stock outside the agreed terms, or (h) circumventing any rights set forth in the Certificate of Designation.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 10 - Redeemable Convertible Preferred Stock (Continued)**

*Change of Control Exchange.* Upon a change of control of the Company, each holder may require the Company to exchange such holder's shares of Series A Preferred Stock for consideration equal to the Conversion Amount (or (1) the Series A Stated Value thereof plus (2) all declared and unpaid dividends on such shares as of such date of determination plus (3) any other amounts thereon owed to such holder, pursuant to the Certificate of Designation or any other Transaction Document that have not otherwise been paid or satisfied, in the case of any shares of Series A Preferred Stock funded following the Announcement Time (as defined in the Certificate of Designation) but prior to the date of the change of control.

*Company Optional Redemption.* The Company can redeem all or part of the outstanding Series A Preferred Stock at any time by sending a written notice to each holder. The redemption price is generally the Conversion Amount, but may be the Stated Value in certain cases. If a Triggering Event has occurred, the price will be the greater of (i) the Conversion Amount or (ii) the product of the Conversion Rate and the average of the five highest daily VWAPs of the common stock from the day before the company optional redemption notice to the day before the payment is required.

*Fundamental Transactions.* The Certificate of Designation prevents the Company from engaging in fundamental transactions, such as mergers or business combinations, unless it (or its successor) assumes all obligations under the Certificate of Designation and Transaction Documents, or redeems all outstanding Series A Preferred Stock.

*Covenants.* The Certificate of Designation imposes several restrictions on the Company, including prohibiting the redemption, repurchase, or declaration of dividends on capital stock (except as required), incurring debt (except Permitted Indebtedness), entering into affiliate transactions, or creating liens without the Required Holder's prior consent. Additionally, the Company cannot issue Series A Preferred Stock or other securities that would violate the Certificate of Designation or issue securities below the current Floor Price.

The Company evaluated the features of the Series A Preferred Stock to determine if any needed to be bifurcated as embedded derivatives. It concluded that the conversion feature is closely related to the host contract, while the redemption feature qualifies for bifurcation as a derivative. However, the fair value of the bifurcated derivative is immaterial. While the host contract is considered as an equity-classified instrument, it includes provisions that allow the investor to redeem the instrument for cash or other assets upon the occurrence of events that are not solely within the company's control, the Series A Preferred Stock is classified as mezzanine equity.

As a result, the Company bifurcated the Redeemable Convertible Preferred Stock into (i) the host contract, classified within mezzanine equity, and (ii) the bifurcated derivative liability related to the redemption feature.

The proceeds from the Initial Offerings were allocated first to the fair value of the Private Placement Convertible Preferred Warrants, with the remaining balance allocated to the Redeemable Convertible Preferred Stock. The Private Placement Convertible Preferred Warrants do not meet equity classification requirements under ASC 815-40, so they are treated as derivative liabilities, remeasured to fair value each reporting period, with changes recorded in the consolidated statement of operations and comprehensive loss.

From the issuance date through June 30, 2025, 664 shares of Series A Preferred Stock were converted into 29,996,775 shares of common stock. As a result, $6,085 (net of offering costs) was reclassified from mezzanine equity to common stock and additional paid-in capital.

As of June 30, 2025, 136 shares of Series A Preferred Stock remained outstanding, with an aggregate stated value of $1,356 ($1,245 net of fees). Subsequent to June 30, 2025 but prior to July 20, 2025, the Company converted 3 shares of Series A Preferred Stock, with a stated value of $31, into 217,840 shares of common stock. The remaining 133 shares of Series A Preferred Stock, representing $1,325 of stated value, were exchanged on July 20, 2025 for 2,100,000 shares of common stock pursuant to a negotiated agreement with the holder. As a result of the exchange, the holder surrendered to the Company all of the outstanding shares of Series A Preferred Stock and no shares of Series A Preferred Stock remained outstanding after the exchange.

At June 30, 2025, the Company did not have a sufficient number of registered shares to fully satisfy the conversion of the remaining Series A Preferred Stock under either the floor conversion price of $0.424, which would have required approximately 3,198,113 shares, or the Alternate Conversion Price of $0.144, which would have required approximately 9,407,670 shares (based on 90% of the lowest VWAP over the 10 trading days prior to June 30, 2025). The impact of the Company not having a sufficient number of registered shares to fully satisfy the conversion of the remaining Series A Preferred Stock would be an immaterial reclass to a derivative liability. Subsequent to June 30, 2025, the Company entered into negotiated share settlement terms, as discussed in Note 15, Subsequent Events, which addressed these limitations.

These limitations contributed to the negotiated share settlement terms.

The 2,100,000 shares issued on July 20, 2025 and the 217,840 shares issued shortly after quarter end were excluded from the calculation of diluted earnings per share as of June 30, 2025, because their effect was anti-dilutive.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 11 - Common Stock**

No dividends on common stock had been declared by the Company.

For the six months ended June 30, 2025 and 2024, the Company had reserved shares of common stock for issuance as follows:

SUMMARY OF RESERVED SHARES OF COMMON STOCK FOR ISSUANCE

---

| | | |
|:---|:---|:---|
|  | June 30, 2025 | June 30, 2024 |
| Options issued and outstanding | 158247 | 212091 |
| Common stock outstanding | 37426379 | 6818626 |
| Warrants outstanding | 4256156 | 3240917 |
| Earnout shares | 2777778 | 2777778 |
| Series Preferred Stock A outstanding\*\*\* | 2317840 |  |
| Shares available for future issuance | 1189254 | 995237 |
| Total | 48125654 | 14044649 |

---

\*\*\* See Note 10 for further information.

*ChEF Equity Facility*

 

The Company and Chardan Capital Markets LLC, a New York limited liability company ("CCM LLC") entered into a purchase agreement (the "Original Purchase Agreement") and a Registration Rights Agreement in connection with the merger. Pursuant to the Original Purchase Agreement, the Company has the right to sell to CCM LLC an amount of shares of common stock, up to a maximum aggregate purchase price of $150 million, pursuant to the terms of the Purchase Agreement (the "ChEF Equity Facility"). In addition, the Company appointed LifeSci Capital, LLC as "qualified independent underwriter" with respect to the transactions contemplated by the Purchase Agreement. Under the terms of the Purchase Agreement with CCM LLC, the Company issued 23,160 shares for aggregate net proceeds to the Company of $63 from the period January 1, 2025 through June 30, 2025. The Company issued 94,496 shares pursuant to the ChEF Equity Facility for aggregate proceeds to the Company of $737 for the period of January 1, 2024 through June 30, 2024.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 12 - Stock-Based Compensation**

The Company maintains the Dragonfly Energy Holdings Corp. Employee Stock Purchase Plan (the "ESPP") which is designed to allow eligible employees and the eligible employees of the Company's participating subsidiaries to purchase shares of the Company's common stock, at semi-annual intervals, with their accumulated payroll deductions. A total of 273,822 shares of the Company's common stock were initially available for issuance under the ESPP. The share limit will automatically increase on the first trading day in January of each year by an amount equal to lesser of (1) 1% of the total number of outstanding shares of the Company's common stock on December 31 in the prior year, (2) 166,667 shares, or (3) such number as determined by the Company's board of directors.

A summary of the Company's option activity and related information follows:

SCHEDULE OF OPTION ACTIVITY AND RELATED INFORMATION

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Number of <br>Options | Weighted-Average Exercise Price | Weighted-Average Grant Date Fair Value | Weighted-Average Remaining Contractual Life (in years) | Aggregate intrinsic value |
| Balances, January 1, 2025 | 168809 | $25.97 | $25.97 | 6.50 | $- |
| Options granted |  |  |  |  |  |
| Options forfeited | (2262) | 34.79 | 34.79 |  |  |
| Options expired | (8300) | 30.79 | 30.79 |  |  |
| Options exercised | - | - | - | - | - |
| Balances, June 30, 2025 | 158247 | $25.59 | $25.59 | 6.23 | $- |
| At June 30, 2025 |  |  |  |  |  |
| Vested and Exercisable | 150052 | 24.90 |  | 6.19 | $- |
| Vested and expected to vest | 158247 | 25.59 |  | 6.23 | $- |

---

During the six months ended June 30, 2025, the Company did not issue any stock options.

Share-based compensation expense for options and restricted stock units ("RSUs") totaling $410 and $503 was recognized in the Company's consolidated statements of operations for the six months ended June 30, 2025 and 2024, respectively. Share-based compensation expense for options and RSUs totaling $190 and $237 was recognized in the Company's consolidated statements of operations for the three months ended June 30, 2025 and 2024, respectively.

Of the $410 of share-based compensation incurred during the six months ended June 30, 2025, $35 is allocated to cost of goods sold, $26 to research and development, $124 to selling and marketing, and $225 to general and administrative expenses. Of the $503 of share-based compensation incurred during the six months ended June 30, 2024, $60 is allocated to cost of goods sold, $101 to research and development, $127 to selling and marketing, and $215 to general and administrative expenses.

Of the $190 of share-based compensation incurred during the three months ended June 30, 2025, $17 is allocated to cost of goods sold, $12 to research and development, $63 to selling and marketing, and $98 to general and administrative expenses. Of the $237 of share-based compensation incurred during the three months ended June 30, 2024, $28 is allocated to cost of goods sold, $36 to research and development, $67 to selling and marketing, and $106 to general and administrative expenses.

*Restricted Stock Units*

 

On February 5, 2024, the Company granted 24,447 RSUs of which 11,111 vested immediately. The fair value of the 24,447 RSUs was $95 and an expense of $5 and $48 was recorded as compensation expense during the six months ended June 30, 2025 and 2024, respectively.

On April 12, 2024, the Company issued a total of 92,923 RSUs to the following employees: (i) 63,045 RSUs to the Chief Executive Officer; (ii) 20,165 RSUs to the Chief Revenue Officer; and (iii) 9,712 RSUs to the Chief Marketing Officer. Each of the RSUs granted will vest in three equal annual installments, with the first vesting date on the one (1) year anniversary of the date of issuance and the following two vesting dates on each subsequent anniversary of the date of issuance, subject to each employees' continued employment as of each vesting date. The fair value of the 92,923 RSUs was $376 and an expense of $62 and $71 was recorded during the six months ended June 30, 2025 and 2024, respectively.

On April 12, 2024, the board of directors authorized the issuance of 24,692 RSUs to each director in connection with their service as directors for the year ended December 31, 2023. The RSUs will vest in three equal annual installments, with the first vesting date on the one (1) year anniversary date of their issuance, subject to the directors' continued service on with the Company on each vesting date. The fair value of the 148,152 RSUs issued to directors in total was $600 and an expense of $77 and $44 was recorded during the six months ended June 30, 2025 and 2024, respectively.

On June 24, 2024, the Company granted 2,417 RSUs. The fair value of the 2,417 RSUs was $19 and an expense of $2 and $1 was recorded as compensation expense during the six months ended June 30, 2025 and 2024, respectively.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 12 - Stock-Based Compensation (continued)**

*Restricted Stock Units (Continued)*

On April 1, 2025 and May 19, 2025, the Company granted 3,778 and 889 RSUs, respectively. The fair value of the RSUs was $4 and no expense was recorded as compensation expense during the six months ended June 30, 2025 and 2024, respectively.

The following table presents the restricted stock units activity for the six months ended June 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | Number of <br>Shares | Weighted-Average Fair Market Value |
| Unvested shares, January 1, 2025 | 334751 | $4.54 |
| Granted and unvested | 4667 | 0.87 |
| Forfeited | (58504) | 4.26 |
| Vested | (85036) | 4.19 |
| Unvested shares, June 30, 2025 | 195878 | $4.69 |

---

As of June 30, 2025 and 2024 there were 1,189,254 and 995,237 shares, respectively, of unissued authorized and available for future awards under the 2022 Equity Incentive Plan and Employee Stock Purchase Plan.

*Employee Stock Purchase Plan*

 

The Company maintains the Dragonfly Energy Corporation, Inc. Employee Stock Purchase Plan ("ESPP") which permits eligible employees to purchase shares at not less than 85% of the market value of the Company's common stock on the offering date or the purchase date of the applicable offering period, whichever is lower. The plan was adopted by the Company's Board of Directors on May 13, 2022.

On April 24, 2024, the Company issued 27,197 shares of common stock in connection with the ESPP for a total consideration of approximately $112. The ESPP allows employees to purchase shares at a 15% discount to the lesser of the stock price at the beginning or the end of the offering period, which was October 1, 2023, and April 1, 2024, respectively. The discount resulted in an exercise price of $4.14 per share.

During the six months ended June 30, 2025, the Company issued 87,506 common shares in connection with teh ESPP for a total consideration of approximately $73. The ESPP allows employees to purchase shares at a 15% discount to the lesser of the stock price at the beginning or the end of the offering period, which was October 1, 2024, and April 1, 2025, respectively. The discount resulted in an exercise price of $0.83 per share.

**Note 13 - Supplier Agreement**

On May 9, 2023, Ioneer Rhyolite Ridge LLC, or the seller, an emerging lithium-boron producer, and the Company announced a commercial offtake agreement partnership whereby the seller is developing the Rhyolite Ridge Project which, once completed, is expected to produce 20 ktpa of lithium carbonate, and 174 ktpa of boic acid (the "project"). Beginning on the Supply Start Date which is the date the seller notifies the Company that the project is fully completed and commissioned in accordance with the engineering, procurement and construction contract, and for the duration of the supply period, the Company shall purchase and receive product from seller, on the terms and conditions of the agreement. The agreement calls for a minimum annual purchase requirement. The agreement becomes effective when the seller has informed the Company that the seller has made a positive financial investment decision in respect of the project.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments**

The Company has two reportable segments: DTC and OEM. The DTC segment pertains to Battle Born, LLC branded batteries which are sold directly to consumers. The OEM segment pertains to Dragonfly branded batteries which are sold to original equipment manufacturers

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance for all of its reportable segments based on both segment gross and net profit or loss from operations.

For the DTC and OEM, the Chief Operating Decision Maker ("CODM") uses both segment gross and net profit and loss from operations to allocate resources (including employees, property, and financial or capital resources) for each segment predominantly in the annual budget and forecasting process.

Assets information for the reported segments is not disclosed as it is not used by the CODM in evaluating the performance of, or making decisions about, the reported segments.

The Company's reportable segments are strategic business units that offer different branded products. They are managed separately because each segment requires different technology and marketing strategies.

The Company's CODM is the Chief Executive Officer.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

The following table presents the reportable segments information for the six months ended June 30, 2025:

SCHEDULE OF REPORTABLE SEGMENTS INFORMATION

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **DTC** | **OEM** | **Other** | **Total** |
| **Net Sales** | $10963 | $18141 | $500<sup>(1)</sup> | $29604 |
| *Reconciliation of Net Sales* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated Net Sales |  |  |  | $29604 |
| Direct material | 6488 | 10752 |  | 17240 |
| Direct labor | 691 | 988 |  | 1679 |
| Direct overhead and depreciation | 886 | 1266 | - | 2152 |
| &nbsp;&nbsp;&nbsp;**Total Cost of Goods Sold** | 8065 | 13006 |  | 21071 |
| **Gross profit** | 2898 | 5135 | 500 | 8533 |
| **Operating Expenses** |  |  |  |  |
| Research & development |  |  | 1692<sup>(2)</sup> | 1692 |
| Sales tax adjustment | 2 |  |  | 2 |
| Credit card & amazon transaction fees | 258 |  |  | 258 |
| Other general & administrative |  |  | 10716<sup>(3)</sup> | 10716 |
| Shipping | 810 | 579 |  | 1389 |
| Sales and marketing stock compensation | 18 | 75 |  | 93 |
| Sales and marketing wages | 375 | 665 |  | 1040 |
| Marketing spend | 1323 | 120 |  | 1443 |
| Rent | 27 | 9 |  | 36 |
| Unallocated sales and marketing stock compensation |  |  | 31<sup>(4)</sup> | 31 |
| Unallocated sales and marketing wages |  |  | 624<sup>(4)</sup> | 624 |
| Other sales & marketing | - | - | 404<sup>(4)</sup> | 404 |
| &nbsp;&nbsp;&nbsp;**Total Operating Expenses** | 2813 | 1448 | 13467 | 17728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | 85 | 3687 | (12967) | (9195) |
| Interest expense, net |  |  | (10143)<sup>(5)</sup> | (10143) |
| Change in FMV of warrant liability | - | - | 5507<sup>(5)</sup> | 5507 |
| &nbsp;&nbsp;&nbsp;**Total Other Income (Expense)** |  |  | (4636) | (4636) |
| **Net Loss Before Taxes** | 85 | 3687 | (17603) | (13831) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Income (Loss)** | $85 | $3687 | $(17603) | $(13831) |
| *Reconciliation of net loss* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated net loss |  |  |  | $(13831) |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Licensing Revenue
which is not considered a segment as it is currently immaterial

&nbsp;&nbsp;&nbsp;&nbsp;(2) Research and Development
expenses including employee costs related to new products

&nbsp;&nbsp;&nbsp;&nbsp;(3) Administrative
and Engineering employee costs along with legal, insurance, professional fees related to administration and other general office expenses

&nbsp;&nbsp;&nbsp;&nbsp;(4) General sales and
marketing employee cost and other marketing expenses

&nbsp;&nbsp;&nbsp;&nbsp;(5) Interest expense
related to debt and change in fair market value of warrant liability

There were no significant customer revenues from the Company's DTC segment for the six months ended June 30, 2025.

Revenues from one customer of the Company's OEM segment represent approximately $7,446, or 26%, of the Company's consolidated revenues for the six months ended June 30, 2025.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

The following table presents the reportable segments information for the six months ended June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **DTC** | **OEM** | **Other** | **Total** |
| **Net Sales** | $11737 | $13976 | $- | $25713 |
| *Reconciliation of Net Sales* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated Net Sales |  |  |  | $25713 |
| Direct material | 6755 | 8910 |  | 15665 |
| Direct labor | 732 | 946 |  | 1678 |
| Direct overhead and depreciation | 938 | 1214 | - | 2152 |
| &nbsp;&nbsp;&nbsp;**Total Cost of Goods Sold** | 8425 | 11070 |  | 19495 |
| **Gross profit** | 3312 | 2906 |  | 6218 |
| **Operating Expenses** |  |  |  |  |
| Research & development |  |  | 2864<sup>(1)</sup> | 2864 |
| Sales tax adjustment | 60 |  |  | 60 |
| Credit card & amazon transaction fees | 302 |  |  | 302 |
| Other general & administrative |  |  | 10155<sup>(2)</sup> | 10155 |
| Shipping | 696 | 561 |  | 1257 |
| Sales and marketing stock compensation | 28 | 73 |  | 101 |
| Sales and marketing wages | 416 | 738 |  | 1154 |
| Marketing spend | 629 | 237 |  | 866 |
| Rent | 29 | 7 |  | 36 |
| Unallocated sales and marketing stock compensation |  |  | 657<sup>(3)</sup> | 657 |
| Unallocated sales and marketing wages |  |  | 25<sup>(3)</sup> | 25 |
| Other sales & marketing | - | - | 1329<sup>(3)</sup> | 1329 |
| &nbsp;&nbsp;&nbsp;**Total Operating Expenses** | 2160 | 1616 | 15030 | 18806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Loss from Operations** | 1152 | 1290 | (15030) | (12588) |
| Other income (expense) |  |  | (23) | (23) |
| Interest expense, net |  |  | (9638)<sup>(4)</sup> | (9638) |
| Change in FMV of warrant liability | - | - | (1745)<sup>(4)</sup> | (1745) |
| &nbsp;&nbsp;&nbsp;**Total Other Income (Expense)** |  |  | (11406) | (11406) |
| **Net Loss before taxes** | 1152 | 1290 | (26436) | (23994) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Income (Loss)** | $1152 | $1290 | $(26436) | $(23994) |
| *Reconciliation of net loss* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated net loss |  |  |  | $(23994) |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Research and Development
expenses including employee costs related to new products

&nbsp;&nbsp;&nbsp;&nbsp;(2) Administrative
and Engineering employee costs along with legal, insurance, professional fees related to administration and other general office expenses

&nbsp;&nbsp;&nbsp;&nbsp;(3) General sales and
marketing employee cost and other marketing expenses

&nbsp;&nbsp;&nbsp;&nbsp;(4) Interest expense
related to debt and change in fair market value of warrant liability

There were no significant customer revenues from the Company's DTC segment for the six months ended June 30, 2024.

Revenues from one customer of the Company's OEM segment represent approximately $3,526, or 14%, of the Company's consolidated revenues for the six months ended June 30, 2024.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

The following table presents the reportable segments information for the three months ended June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **DTC** | **OEM** | **Other** | **Total** |
| **Net Sales** | $5947 | $10051 | $250<sup>(1)</sup> | $16248 |
| *Reconciliation of Net Sales* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated Net Sales |  |  |  | $16248 |
| Direct material | 3599 | 6093 |  | 9692 |
| Direct labor | 370 | 504 |  | 874 |
| Direct overhead and depreciation | 457 | 620 | - | 1077 |
| &nbsp;&nbsp;&nbsp;**Total Cost of Goods Sold** | 4426 | 7217 |  | 11643 |
| **Gross profit** | 1521 | 2834 | 250 | 4605 |
| **Operating Expenses** |  |  |  |  |
| Research & development |  |  | 692<sup>(2)</sup> | 692 |
| Sales tax adjustment |  |  |  |  |
| Credit card & amazon transaction fees | 144 |  |  | 144 |
| Other general & administrative |  |  | 4475<sup>(3)</sup> | 4475 |
| Shipping | 472 | 292 |  | 764 |
| Sales and marketing stock compensation | 8 | 37 |  | 45 |
| Sales and marketing wages | 178 | 354 |  | 532 |
| Marketing spend | 648 | 49 |  | 697 |
| Rent | 13 | 5 |  | 18 |
| Unallocated sales and marketing stock compensation |  |  | 332<sup>(4)</sup> | 332 |
| Unallocated sales and marketing wages |  |  | 17<sup>(4)</sup> | 17 |
| Other sales & marketing | - | - | 170<sup>(4)</sup> | 170 |
| &nbsp;&nbsp;&nbsp;**Total Operating Expenses** | 1463 | 737 | 5686 | 7886 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | 58 | 2097 | (5436) | (3281) |
| Interest expense, net |  |  | (5442)<sup>(5)</sup> | (5442) |
| Change in FMV of warrant liability | - | - | 1689<sup>(5)</sup> | 1689 |
| &nbsp;&nbsp;&nbsp;**Total Other Income (Expense)** |  |  | (3753) | (3753) |
| **Net Loss Before Taxes** | 58 | 2097 | (9189) | (7034) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Income (Loss)** | $58 | $2097 | $(9189) | $(7034) |
| *Reconciliation of net loss* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated net loss |  |  |  | $(7034) |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Licensing Revenue
which is not considered a segment as it is currently immaterial

&nbsp;&nbsp;&nbsp;&nbsp;(2) Research and Development
expenses including employee costs related to new products

&nbsp;&nbsp;&nbsp;&nbsp;(3) Administrative
and Engineering employee costs along with legal, insurance, professional fees related to administration and other general office expenses

&nbsp;&nbsp;&nbsp;&nbsp;(4) General sales and
marketing employee cost and other marketing expenses

&nbsp;&nbsp;&nbsp;&nbsp;(5) Interest expense
related to debt and change in fair market value of warrant liability

There were no significant customer revenues from the Company's DTC segment for the three months ended June 30, 2025.

Revenues from one customer of the Company's OEM segment represent approximately $5,147, or 32%, of the Company's consolidated revenues for the three months ended June 30, 2025.

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

The following table presents the reportable segments information for the three months ended June 30, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **DTC** | **OEM** | **Other** | **Total** |
| **Net Sales** | $6534 | $6674 | $- | $13208 |
| *Reconciliation of Net Sales* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated Net Sales |  |  |  | $13208 |
| Direct material | 3818 | 4379 |  | 8197 |
| Direct labor | 362 | 447 |  | 809 |
| Direct overhead and depreciation | 462 | 573 | - | 1035 |
| &nbsp;&nbsp;&nbsp;**Total Cost of Goods Sold** | 4642 | 5399 |  | 10041 |
| **Gross profit** | 1892 | 1275 |  | 3167 |
| **Operating Expenses** |  |  |  |  |
| Research & development |  |  | 1531<sup>(1)</sup> | 1531 |
| Sales tax adjustment | 61 |  |  | 61 |
| Credit card & amazon transaction fees | 155 |  |  | 155 |
| Other general & administrative |  |  | 5488<sup>(2)</sup> | 5488 |
| Shipping | 401 | 281 |  | 682 |
| Sales and marketing stock compensation | 13 | 39 |  | 52 |
| Sales and marketing wages | 252 | 385 |  | 637 |
| Marketing spend | 254 | 113 |  | 367 |
| Rent | 15 | 4 |  | 19 |
| Unallocated sales and marketing stock compensation |  |  | 268<sup>(3)</sup> | 268 |
| Unallocated sales and marketing wages |  |  | 14<sup>(3)</sup> | 14 |
| Other sales & marketing | - | - | 642<sup>(3)</sup> | 642 |
| &nbsp;&nbsp;&nbsp;**Total Operating Expenses** | 1151 | 822 | 7943 | 9916 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Loss from Operations** | 741 | 453 | (7943) | (6749) |
| Other income (expense) |  |  | (19) | (19) |
| Interest expense, net |  |  | (4878)<sup>(4)</sup> | (4878) |
| Change in FMV of warrant liability | - | - | (1981)<sup>(4)</sup> | (1981) |
| &nbsp;&nbsp;&nbsp;**Total Other Income (Expense)** |  |  | (6878) | (6878) |
| **Net Loss before taxes** | 741 | 453 | (14821) | (13627) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Income (Loss)** | $741 | $453 | $(14821) | $(13627) |
| *Reconciliation of net loss* |  |  |  |  |
| Reconciling items |  |  |  | - |
| Consolidated net loss |  |  |  | $(13627) |

---

**Dragonfly Energy Holdings Corp.**

**Notes to Consolidated Financial Statements**

**(in thousands, except share and per share data)**

**Note 14 - Reportable Segments (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Research and Development
expenses including employee costs related to new products

&nbsp;&nbsp;&nbsp;&nbsp;(2) Administrative
and Engineering employee costs along with legal, insurance, professional fees related to administration and other general office expenses

&nbsp;&nbsp;&nbsp;&nbsp;(3) General sales and
marketing employee cost and other marketing expenses

&nbsp;&nbsp;&nbsp;&nbsp;(4) Interest expense
related to debt and change in fair market value of warrant liability

There were no significant customer revenues from the Company's DTC segment for the three months ended June 30, 2024.

Revenues from one customer of the Company's OEM segment represent approximately $1,561, or 12%, of the Company's consolidated revenues for the three months ended June 30, 2024.

**Note 15 - Subsequent Events**

*Series A Preferred Stock Exchange*

 

On July 20, 2025, the Company entered into a Settlement and Release Agreement (the "Release Agreement") with the holder of the outstanding shares of Series A Preferred Stock. Pursuant to the terms of the Release Agreement, the Company issued and delivered 2,100,000 shares of common stock to the holder and the holder surrendered to the Company all of the outstanding shares of Series A Preferred Stock. In addition, under the Release Agreement, upon the issuance of the shares of common stock, the Company's obligations under the Purchase Agreement, the Certificate of Designation governing the Series A Preferred Stock and the other agreements entered into in connection with the offering of the Series A Preferred Stock were satisfied in full and the Purchase Agreement and the other agreements were deemed terminated and any remaining shares of Series A Preferred Stock that were outstanding or deemed to be outstanding were deemed cancelled and no longer outstanding. The Company has no further obligation to issue any shares of common stock or Series A Preferred Stock to the holder under the Purchase Agreement or otherwise. Under the Release Agreement, each party also provided a full release to the other party.

 

*Public Offering* 

On July 30, 2025, the Company entered into an underwriting agreement with Canaccord Genuity LLC, as underwriter, relating to an underwritten public offering of 21,980,000 shares of common stock, at a price to the public of $0.25 per share. On July 31, 2025, the Company completed the public offering raising gross proceed of approximately $5.5 million and net proceeds of $5.035 million after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*References in this report (the "Quarterly Report") to "we," "us," "our" or the "Company" refer to Dragonfly Energy Holdings Corp., a Nevada corporation. References to "Legacy Dragonfly" refer to Dragonfly Energy Corp., a Nevada corporation and one of our wholly-owned subsidiaries. The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.*

*As a result of the completion of the Business Combination (as defined herein), the financial statements of Legacy Dragonfly are now the financial statements of us. Prior to the Business Combination, we had no operating assets but, upon consummation of the Business Combination, the business and operating assets of Legacy Dragonfly acquired by us became our sole business and operating assets. Accordingly, the financial statements of Legacy Dragonfly and their respective subsidiaries as they existed prior to the Business Combination and reflecting the sole business and operating assets of the Company going forward, are now the financial statements of us.*

*The following discussion and analysis of our financial condition and results of operations should be read together with our financial statements and the related notes and the other financial information included elsewhere in this Quarterly Report and with our audited consolidated financial statements (and notes thereto) for the year ended December 31, 2024 included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 31, 2025 (the "Annual Report"), particularly those under "Risk Factors." This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report. We undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date of this report or to reflect actual outcomes.*

**Cautionary Note Regarding Forward Looking-Statements**

This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 under Section 27A of the Securities Act of 1933, as amended (the "**Securities Act**"), and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "can," "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "seek," "estimate," "continue," "plan," "point to," "project," "predict," "could," "intend," "target," "potential" and other similar words and expressions of the future.

There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include, but are not limited to:

● our ability to service our outstanding indebtedness and comply with the financial covenants in our loan agreement, the failure of which could allow our lenders to accelerate payment under our loan agreement, which would have a material adverse effect on our ability to operate and could require us, among other things, to reduce operations, sell off our assets, seek the protection of bankruptcy courts or shut down our operations and dissolve;

● our ability to raise additional capital to fund our operations;

● our ability to successfully increase market penetration into target markets;

● our ability to cure any listing deficiencies and maintain the listing of our common stock and Public Warrants on the Nasdaq Capital Market;

● the addressable markets that we intend to target do not grow as expected;

● the potential for events or circumstances that result in our failure to timely achieve the anticipated benefits of our customer arrangements with THOR Industries and its affiliate brands (including Keystone RV Company ("Keystone")), including Keystone's decision in July 2023, that, due to weaker demand for its products and its subsequent focus on reducing costs, it would no longer install our storage solutions as standard equipment, but rather return to offering those solutions as an option to dealers and consumers;

● our ability to generate revenue from future product sales in our existing markets or new markets that we enter, including the trucking and industrials markets, and our ability to achieve and maintain profitability;

● the loss of any members of our senior management team or other key personnel;

● the loss of any relationships with key suppliers, including suppliers in China;

● the loss of any relationships with key customers;

● our ability to protect our patents and other intellectual property;

● our ability to engage target customers and successfully retain these customers for future orders;

● the failure to successfully optimize solid-state cells or to produce commercially viable solid-state cells in a timely manner or at all, or to scale to mass production;

● the failure to produce lithium battery cells in the United States in a timely manner or at all, or to scale to mass production;

● the failure to timely achieve the anticipated benefits of our recent licensing arrangement with Stryten Energy LLC ("Stryten");

● changes in applicable laws or regulations, including changes in the rates of tariffs or any adjustments to the amounts payable by us to customs as a result of improperly identifying the applicable tariff rate payable on our products;

● the possibility that we may be adversely affected by other economic, business and/or competitive factors (including an economic slowdown or inflationary pressures);

● our ability to sell the desired amounts of shares of common stock at desired prices under our committed equity facility;

● the accuracy of our projections and estimates regarding our expenses, capital requirements, cash utilization, and need for additional financing;

● developments relating to our competitors and our industry;

● the reliance on two suppliers for our lithium iron phosphate cells and a single supplier for the manufacture of our battery management system;

● our current dependence on one manufacturing facility; and

● the potential impact of global and macroeconomic conditions, including economic, political and social instability, including the Russia-Ukraine conflict, the India-Pakistan conflict and Hamas' attack on Israel, and their effects on our operations.

The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may cause our actual results to differ from those anticipated in such forward-looking statements. Please see "*Part I-Item 1A-Risk Factors*" of our Annual Report and in this Quarterly Report for additional risks which could adversely impact our business and financial performance.

All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Quarterly Report or the date of the document incorporated by reference into this report. We have no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise. We have expressed our expectations, beliefs and projections in good faith and believe they have a reasonable basis. However, we cannot assure you that our expectations, beliefs or projections will result or be achieved or accomplished.

**Overview**

*Our Business*

We are a manufacturer of non-toxic deep cycle lithium-ion batteries that caters to customers in the consumer industry (including the recreational vehicle ("RV"), marine vessel, solar and off-grid residence industries), and trucking, industrial and energy storage markets, with proprietary, patented and disruptive battery cell manufacturing and non-flammable solid-state cell technology currently under development.

Since 2020, we have sold over 350,000 batteries. For the quarters ended June 30, 2025, and June 30, 2024, we sold 12,134 and 11,526 batteries, respectively, and had $16.2 million and $13.2 million in net sales, respectively. For the six months ended June 30, 2025 and June 30, 2024, we sold 22,979 and 22,624 batteries, respectively, and had $29.6 million and $25.7 million in net sales, respectively. We currently offer several lines of batteries across our two brands, each differentiated by size, power and capacity, consisting of seven different models, which come with an option for internal heat for cold temperature operation or an option for wireless communication using our Dragonfly IntelLigence feature. We primarily sell "Battle Born" branded batteries directly to consumers ("DTC") and "Dragonfly" branded batteries to original equipment manufacturers ("OEMs").

Our increase in sales is a reflection of a slight recovery in the motorized RV market and increased market penetration as compared to prior quarter and prior year. Although our existing RV OEM customers have only slightly increased their year-over-year production rates, the incorporation of lithium storage systems has accelerated faster than the increase in RV units shipped. This is in contrast to the de-contenting trend that had occurred over the previous 18 months. DTC sales remained relatively flat, indicating generally constant consumer sentiment in the space.

During the second quarter of 2025, we continued to implement our corporate optimization initiative, prioritizing product development to drive near term revenue and profit. For instance, this strategic shift is accelerating our development of purpose-built solutions for the trucking and industrial markets, resulting in the recent launch of our Battle Born DualFlow Power Pack, a practical, cost-effective hybrid electrification solution for the trucking industry.

We currently source the lithium iron phosphate ("LFP") cells incorporated into our batteries from a limited number of carefully selected suppliers that can meet our demanding quality standards and with whom we have developed long-term relationships.

To supplement our battery offerings, we are also a reseller of accessories for battery systems. These include chargers, inverters, monitors, controllers and other system accessories from brands such as Victron Energy, Progressive Dynamics, Magnum Energy and Sterling Power. Pursuant to the Asset Purchase Agreement dated April 22, 2022 by and among us and Thomason Jones Company, LLC ("Thomason Jones") and the other parties thereto, we also acquired the assets, including the Wakespeed Offshore brand ("Wakespeed") of Thomason Jones, allowing us to include our own alternator regulator in systems that we sell.

In addition to our conventional LFP batteries, we have been developing proprietary dry electrode cell manufacturing processes and solid-state cell technology. We believe that our solid-state technology design allows for a much safer, more efficient battery cell that we believe will be a key differentiator in the energy storage market.

In July 2023, we completed the construction of our proprietary and patented cell electrode manufacturing pilot line. Our patented dry deposition process is chemistry agnostic – meaning it can produce battery cells across a variety of chemistries – and is less capital intensive, uses less energy, and can produce cells in a smaller manufacturing footprint, leading to a lower total cost of manufacturing. In August 2023, we successfully demonstrated the ability to produce anode material at scale using this manufacturing process and did the same with cathode material in October 2023. We have since produced sample cells using PFAS-free binders and automotive-grade electrode loadings and C-rates, and are now working on the design and deployment of scaled-up coating equipment that can be applied to a GWh-scale factory, reflecting the shift in industry priorities from cell performance to cost-effective scalability.

As of June 30, 2025, we had cash totaling $2.7 million. Our net loss for the quarter ended June 30, 2025 was $7.0 million and our net loss for the quarter ended June 30, 2024 was $13.6 million. In addition, in April 2025, we completed the second closing of shares of our Series A Convertible Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock") which provided us with additional net proceeds of $4.2 million. On July 30, 2025, we entered into an underwriting agreement with Canaccord Genuity LLC, as underwriter, relating to an underwritten public offering (the "2025 Public Offering") of 21,980,000 shares of common stock, at a price to the public of $0.25 per share. On July 31, 2025, we completed the 2025 Public Offering raising gross proceed of approximately $5.5 million and net proceeds of $5.035 million after deducting underwriting discounts and commissions and other estimated offering expenses payable by us. As discussed under "*—Liquidity and Capital Resources*" below we expect that we will need to raise additional funds, including through the use of the ChEF Equity Facility (as defined below) and the issuance of equity, equity-related or debt securities or by obtaining additional credit from financial institutions to fund, together with our principal sources of liquidity, ongoing costs. If such financings are not available, or if the terms of such financings are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including not seeking potential acquisition opportunities, eliminating redundancies, or reducing or delaying our production facility expansions, reduce operations, sell off our assets, seek the protection of bankruptcy courts or shut down our operations and dissolve.

*License Agreement with Stryten*

On July 29, 2024, Legacy Dragonfly and Battle Born Battery Products, LLC ("Battle Born LLC"), a wholly-owned subsidiary of Legacy Dragonfly, entered into a License Agreement (the "License Agreement") with Stryten. Pursuant to the License Agreement, Battle Born LLC granted Stryten an exclusive, worldwide license to use certain trademarks relating to Legacy Dragonfly's lithium-ion battery brand, Battle Born Batteries® (the "Licensed Trademarks") for business-to-business sales of batteries to customers within the following markets: (i) automative, (ii) marine, (iii) powersports, (iv) lawn and garden, (v) golf cart, and (vi) military and defense (such industries, the "Stryten Market"). In exchange for the licensing rights, Stryten agreed to pay Battle Born LLC an initial licensing fee of $5,000,000 (the "Initial Licensing Fee"), which was paid on August 29, 2024.

The License Agreement provides for mid-single digit royalty payments based on net sales using the Licensed Trademarks, with a tiered structure reaching up to $25,000,000, at which point Stryten will be required to pay a nominal annual license fee. Additional fees will apply for battery design and contract manufacturing services outside of the License Agreement. The License Agreement is perpetual in term, unless terminated by: (i) Battle Born LLC if Stryten fails to pay the royalty payments required by the License Agreement and such royalty payments remain unpaid thirty (30) days after notice of such overdue payments (provided that Battle Born LLC uses reasonable efforts to discuss such overdue payments with Stryten), or (ii) either party (x) if the other party materially breaches the License Agreement and fails to cure such material breach within thirty (30) days of notice of such breach, (y) upon the occurrence of certain bankruptcy-related events, or (z) under certain circumstances, if the aggregate royalty payments received by Battle Born LLC under the License Agreement are less than $15,000,000 after five (5) years.

*Earnout Merger Consideration*

In addition to the initial merger consideration in connection with our business combination, up to 4,444,445 additional shares of common stock ("**Earnout Shares**") may be issued based on achieving specified milestones in three tranches:

&nbsp;&nbsp;&nbsp;&nbsp;1. First Tranche (1,666,667
 shares): Issuable if 2023 total audited revenue is at least $250 million and audited operating income is at least $35 million. This
 milestone was not achieved for 2023.

2. Second Tranche (1,388,889
 shares): Issuable if the volume-weighted average trading price of common stock reaches $202.50 over any 20 trading days within a
 30-day period, on or before December 31, 2026.

3. Third Tranche (1,388,889
 shares): Issuable if the volume-weighted average trading price of common stock reaches $292.50 over any 20 trading days within a
 30-day period, on or before December 31, 2028.

If a change of control occurs during the second or third earnout periods, unachieved milestones will be automatically deemed satisfied if the share price at the time of the transaction meets or exceeds $202.50 for the second period or $292.50 for the third period.

*ChEF Equity Facility*

We and Chardan Capital Markets LLC, a New York limited liability company ("CCM LLC") entered into a purchase agreement (as amended, the "ChEF Purchase Agreement") and a Registration Rights Agreement in connection with our merger in October 2022 (the "Business Combination"). Pursuant to the Original Purchase Agreement, we have the right to sell to CCM LLC an amount of shares of common stock, up to a maximum aggregate purchase price of $150 million, pursuant to the terms of the ChEF Purchase Agreement (the "ChEF Equity Facility"), subject to certain restrictions set forth in the Term Loan Agreement. The ChEF Purchase Agreement terminates in December 2025. In connection with the 2025 Public Offering, we agreed not to sell shares of our common stock for a period of 90 days following the closing of the offering, subject to certain exceptions .

*May 2024 Private Placement*

On May 13, 2024, we received a waiver (the "May 2024 Waiver") from the Term Loan Lenders in regards to our compliance with the Tests (the "Tests") as of the last day of the quarter ended March 31, 2024. The May 2024 Waiver provided for a one-time issuance of penny warrants (the "May 2024 Penny Warrants") to purchase up to 283,334 shares of our common stock (the "May 2024 Penny Warrant Shares"), at an exercise price of $0.09 per share, in connection with the Term Loan Lender's agreement to waive the Tests under the Term Loan for the quarter ended March 31, 2024. The May 2024 Penny Warrants were immediately exercisable upon issuance and will expire ten years from the date of issuance.

*June 2024 Private Placement and First Amendment to Term Loan Agreement*

On June 28, 2024, we received a limited waiver and first amendment (the "First Amendment") to the Term Loan Agreement from the Term Loan Lenders in regards to our compliance with the Tests as of the last day of the quarter ended June 30, 2024. The First Amendment provided for a one-time issuance of penny warrants (the "June 2024 Penny Warrants") to purchase up to 233,334 shares of our common stock (the "June 2024 Penny Warrant Shares"), at an exercise price of $0.09 per share, in connection with the Term Loan Lender's agreement to waive the Tests under the Term Loan for the quarter ended June 30, 2024. The June 2024 Penny Warrants were immediately exercisable upon issuance and will expire ten years from the date of issuance.

In addition, the First Amendment (i) reduced the liquidity requirement under the Term Loan to be $3.5 million as of the last day of the month ended June 30, 2024, and $10.0 million as of the last day of each fiscal month thereafter commencing with the fiscal month ended July 31, 2024 and (ii) provided for the interest to be paid on the Payment Date (as defined in the Term Loan Agreement) occurred on July 1, 2024 to be solely payable-in-kind.

*Second Amendment to Term Loan Agreement*

In connection with the License Agreement, on July 29, 2024, us, Legacy Dragonfly and Battle Born LLC entered into a Limited Waiver, Consent and Second Amendment to the Term Loan, Guarantee and Security Agreement (the "Second Amendment") with the Term Loan Lenders under our Original Term Loan Agreement (as defined below).

Pursuant to the Second Amendment, the Term Loan Lenders (i) consented to the transactions contemplated by the License Agreement and the Trademark Transfer Agreement and (ii) agreed to waive the mandatory prepayment under the Term Loan Agreement that would have been due to the Term Loan Lenders under the Loan Agreement upon Battle Born LLC's receipt of the Initial Licensing Fee.

In connection with the Amendment, Battle Born LLC entered into a Joinder Agreement with the Term Loan Lenders (the "Joinder") whereby Battle Born LLC became a guarantor and credit party to the Term Loan Agreement.

*September 2024 Private Placement and Third Amendment to the Term Loan Agreement*

On September 30, 2024, we received a limited waiver and third amendment (the "Third Amendment") to the Term Loan Agreement from the Term Loan Lenders in regards to our compliance with the Tests as of the last day of the quarter ended September 30, 2024. The Third Amendment provided for a one-time issuance of penny warrants (the "September 2024 Penny Warrants") to purchase up to 333,334 shares of our common stock (the "September 2024 Penny Warrant Shares"), at an exercise price of $0.09 per share, in connection with the Term Loan Lender's agreement to waive the Tests under the Term Loan for the quarter ended September 30, 2024. The September 2024 Penny Warrants were immediately exercisable upon issuance and will expire ten years from the date of issuance.

In addition, the Third Amendment (i) reduced the liquidity requirement under the Term Loan to be $7.0 million as of the last day of the month ended September 30, 2024, and $10.0 million as of the last day of each fiscal month thereafter commencing with the fiscal month ended July 31, 2024 and (ii) on October 1, 2024, interest is payable (a) $1,500,000 in cash pro rata benefit of the Lenders and (b) the remaining interest in-kind, to be capitalized and added to the principal. For Payment Dates occurring on or after January 1, 2025 (including interest accruing from October 1, 2024, through December 31, 2024), all interest shall be paid in cash at a rate equal to Adjusted Term SOFR (as defined in the Term Loan Agreement) plus the Applicable Margin (as defined in the Term Loan Agreement).

*December 2024 Private Placement and Fourth Amendment to the Term Loan Agreement*

On December 31, 2024, we received a limited waiver and fourth amendment (the "Fourth Amendment") to the Term Loan Agreement from the Term Loan Lenders in regards to our compliance with the Tests as of the last day of the quarter ended December 31, 2024. The Fourth Amendment provided for a one-time issuance of penny warrants (the "December 2024 Penny Warrants") to purchase up to 350,000 shares of our common stock (the "December 2024 Penny Warrant Shares"), at an exercise price of $0.01 per share, in connection with the Term Loan Lender's agreement to waive the Tests under the Term Loan for the quarter ended December 31, 2024. The December 2024 Penny Warrants will be exercisable at such time that we obtain the Warrant Issuance Shareholder Approval (as defined below) and will expire ten years from the date of issuance.

In addition, the Fourth Amendment (i) reduced the liquidity requirement under the Term Loan to be $3.5 million as of the last day of the month ended December 31, 2024, and $10.0 million as of the last day of each fiscal month thereafter commencing with the fiscal month ended January 31, 2025 and (ii) on January 1, 2025, interest is payable in-kind, to be capitalized and added to the principal. For Payment Dates occurring on or after April 1, 2025 (including interest accruing from January 1, 2025, through March 31, 2025), all interest shall be paid in cash at a rate equal to Adjusted Term SOFR plus the Applicable Margin.

Pursuant to the Fourth Amendment, we agreed to use commercially reasonable efforts to obtain shareholder approval for the issuance of up to 1,400,000 shares of common stock underlying penny warrants issued to the Term Loan Lenders on and after the date of the Fourth Amendment, including the December 2024 Penny Warrant Shares and the Accrued Warrant Shares (as defined below), in accordance with Rules 5635(b) and 5635(d) of the Nasdaq Stock Market (the "Warrant Issuance Shareholder Approval"). Further, we agreed to issue the Term Loan Lenders additional penny warrants (the "Accrued Penny Warrants") exercisable for a number of shares of common stock pursuant to the formula set forth in the Fourth Amendment (the "Accrued Warrant Shares") upon the earlier to occur of (i) five business days after the end of the Waiver Period (as defined below) or (ii) five business days prior to the effectiveness of a Change of Control (as defined in the Term Loan Agreement), in which such Accrued Penny Warrants would not be exercisable prior to receipt of the Warrant Issuance Shareholder Approval.

Under the Fourth Amendment, the Term Loan Lenders agreed to temporarily suspend the Term Loan Lenders' rights under Section 4(b) of the Penny Warrants to receive additional warrant shares in connection with the issuances by us of shares of common stock pursuant to the ChEF Equity Facility during the Waiver Period. In addition, the Fourth Amendment: (i) provided for the interest to be paid on the Payment Date (as defined in the Term Loan Agreement) occurring on January 1, 2025 to be payable partly in cash and the remainder payable-in-kind as set forth in the Amendment; and (ii) reduced the liquidity requirement under the Term Loan Agreement to be $3.5 million as of the last day of the fiscal month ended December 31, 2024.

*February 2025 Registered Direct Offering and Concurrent Private Placement, Fifth Amendment to Term Loan Agreement and April 2025 Private Placement*

On February 26, 2025, we entered into a securities purchase agreement with a single institutional investor, pursuant to which we sold in a registered direct offering (the "Registered Direct Offering") 180 shares of Series A Preferred Stock, at a price of $10,000 per share, initially convertible into shares of our common stock, at a conversion price of $2.332 per share of common stock. The Series A Preferred Stock is also convertible by the investor at an adjusted conversion price, subject to the applicable floor price, which is based on a discount to the market price of our common stock as set forth in the certificate of designation for the Series A Preferred Stock. The floor price for the Series A Preferred Stock sold in the Registered Direct Offering is $1.00.

Concurrently with the sale of the Series A Preferred Stock in the Registered Direct Offering, in a private placement offering pursuant to the Purchase Agreement (the "Private Placement" and, together with the Registered Direct Offering, the "Offerings"), we sold, at the initial closing of the Private Placement (the "Initial Closing"), (i) an additional 170 shares of Series A Preferred Stock at the same offering price as the Series A Preferred Stock offered in the Registered Direct Offering, initially convertible into shares of common stock at a conversion price of $2.332 per share, and (ii) warrants (the "Private Placement Convertible Preferred Warrants") to purchase up to an aggregate of 4,000 shares of Series A Preferred Stock (the "Private Placement Warrant Shares"), with an exercise price of $10,000 per share of Series A Preferred Stock, and a term as described below. The floor price for the Series A Preferred Stock sold in the Private Placement is $0.424.

The exercise price under each Private Placement Convertible Preferred Warrant will be $10,000 per share of Series A Preferred Stock. Each Private Placement Convertible Preferred Warrant will be exercisable for 200 shares of Series A Preferred Stock in minimum increments of $500,000. The Private Placement Convertible Preferred Warrants will have a term beginning on the issuance date and ending on or prior to the earlier of (i) the thirty-three (33) month anniversary of the date the shares of common stock issued or issuable upon the conversion of the Series A Preferred Stock issued in the concurrent Private Placement are registered for resale ("Registration Effectiveness") pursuant to an effective registration statement under the Securities Act of 1933, as amended, (the "Securities Act") (such date, the "Registration Effectiveness Date") and (ii) (A) the consummation of a Change of Control (as defined in the certificate of designation) and (B) the consummation of a redemption of the then outstanding Series A Preferred Stock in full. The exercise price and number of shares of Series A Preferred Stock issuable upon exercise are subject to appropriate adjustment in the event of share dividends, share splits, reorganizations or similar events affecting shares of our common stock.

Pursuant to the Private Placement Convertible Preferred Warrants, we have a call right upon the occurrence of certain events. No earlier than two (2) months following the Registration Effectiveness Date and (2) the most recent conversion or exercise in full of a Private Placement Convertible Preferred Warrant, (i) the VWAP for each of twenty (20) trading days (the "Measurement Period") exceeds $3.00, (ii) the average daily volume for such Measurement Period exceeds $300,000 per trading day, (iii) the aggregate stated value of the then outstanding Series A Preferred Stock is less than or equal to $1,500,000, (iv) the Private Placement Warrant Shares are registered for resale pursuant to an effective registration statement and (v) there has not been an Equity Conditions Failure (as defined in the certificate of designation), then we may, within one (1) trading day of the end of such Measurement Period, call for cancellation of all or any portion of the Private Placement Convertible Preferred Warrant for which a notice to exercise has not yet been delivered and require the holder to exercise in part or in full the number of shares of Series A Preferred Stock set forth in an irrevocable written notice (a "Call Notice") for consideration equal to the applicable number of Series A Preferred Stock issuable upon exercise or cancellation of the Private Placement Convertible Preferred Warrants.

In addition, upon receipt of stockholder approval pursuant to the rules of Nasdaq for certain shares of common stock issuable upon conversion of the Series A Preferred Stock and the Registration Effectiveness, the investor will be automatically required to purchase for $4.5 million (the "Second Closing") an additional 450 shares of Series A Preferred Stock (the "Second Closing Preferred Shares"). The Second Closing Preferred Shares are identical to the Series A Preferred Stock offered in the Registered Direct Offering and sold in the initial closing of the Private Placement, other than the conversion price and the floor price which was determined at the time of the Second Closing based on the Nasdaq minimum price. On April 28, 2025, pursuant to the Purchase Agreement, we sold to the Purchaser, in the Second Closing 450 Preferred Shares at a price of $10,000 per share, initially convertible into shares of common stock at a conversion price of $0.594 per share. The floor price for the Series A Preferred Stock issued in the Second Closing is $0.10902.

The net proceeds to us from the Initial Offerings and the Second Offering, after deducting the placement agent's fees and expenses and estimated offering expenses, were approximately $3.2 million and $4.2, respectively, excluding the net proceeds, if any, from the exercise of the Private Placement Convertible Preferred Warrants.

As a condition precedent to the closing of the Initial Offerings, on February 26, 2025, we entered into the Fifth Amendment (the "Fifth Amendment") to the Term Loan Agreement with the Term Loan Lenders. Under the Fifth Amendment, the Term Loan Lenders agreed to, among other matters (i) receive no principal or interest payments under the Term Loan Agreement through March 31, 2026, and (ii) remove certain financial covenant tests under the Term Loan, provided that we maintain cash and cash equivalents equal to at least $2.5 million through such date.

Pursuant to the Fifth Amendment, we agreed to make certain mandatory prepayments on the Term Loan upon the occurrence of certain events. We are obligated to make a mandatory prepayment of the Term Loan equal to (i) 100% of the net cash proceeds of certain equity issuances by us made on or after the announcement of a Change of Control (as defined in the Term Loan Agreement), and (ii) 20% of the net cash proceeds of certain equity issuances by us made prior to the announcement of a Change of Control.

In connection with the entry into the Fifth Amendment, we issued to the Term Loan Lenders 330,000 penny warrants (the "February 2025 Penny Warrants") to purchase shares of our common stock at an exercise price of $0.01 per share on the date of the Initial Closing in connection with the waiver of the antidilution provisions in the existing penny warrants held by the Term Loan Lenders with respect to the shares of Series A Preferred Stock issued at the closing of the Registered Direct Offering and the initial closing of the Private Placement. We also agreed to increase the number of shares subject to the Warrant Issuance Shareholder Approval (as defined in the Term Loan Agreement) from 1,400,000 to 3,130,000. Further, we and the Term Loan Lenders agreed to waive the antidilution provisions in the existing penny warrants held by the Lenders with respect to the Private Placement Convertible Preferred Warrants issued at the initial closing of the Private Placement and the shares of Series A Preferred Stock issued at the Second Closing on the condition that we will issue to the Term Loan Lenders a number of penny warrants which will be determined by the parties within five (5) trading days after the end of each fiscal quarter after the Second Closing. We have also agreed that (i) sales of common Stock pursuant to the ChEF Equity Facility shall not exceed 5% of the average daily traded volume of our common stock on any Eligible Market (as defined in the Certificate of Designations), (ii) no share of common stock shall be issued pursuant to the ChEF Equity Facility at a price per share less than the greater of (x) 150% of the Floor Price and (y) $1.00 and (iii) the aggregate proceeds of sales of common stock pursuant to the ChEF Equity Facility shall not exceed $12.0 million; provided, that, with respect to clause (i), such percentage shall increase to 7% after the Registration Effectiveness Date.

On June 23, 2025, we and the holder of Private Placement Convertible Preferred Warrants agreed to cancel such holder's Private Placement Convertible Preferred Warrants to purchase up to an aggregate of 4,000 shares of Series A Preferred Stock, with an exercise price of $10,000 per share of Series A Preferred Stock. As a result, the Private Placement Convertible Preferred Warrants are no longer outstanding.

On July 20, 2025, we entered into a Settlement and Release Agreement (the "Release Agreement") with the holder of the outstanding shares of Series A Preferred Stock. Pursuant to the terms of the Release Agreement, we issued and delivered 2,100,000 shares of common stock to the holder and the holder surrendered to the Company all of the outstanding shares of Series A Preferred Stock. In addition, under the Release Agreement, upon the issuance of the shares of common stock, our obligations under the Purchase Agreement, the Certificate of Designation governing the Series A Preferred Stock and the other agreements entered into in connection with the offering of the Series A Preferred Stock were satisfied in full and the Purchase Agreement and the other agreements were deemed terminated and any remaining shares of Series A Preferred Stock that were outstanding or deemed to be outstanding were deemed cancelled and no longer outstanding. We have no further obligation to issue any shares of common stock or Series A Preferred Stock to the holder under the Purchase Agreement or otherwise. Under the Release Agreement, each party also provided a full release to the other party.

*Change in Board of Directors*

In connection with our efforts to reduce expenses, our Board of Directors approved reducing the size of the Board to five members, and in connection therewith, on May 6, 2025 and May 7, 2025 respectively, Dr. Karina Montilla Edmonds and Mr. Jonathan Bellows resigned as members of the Board, effective immediately. Subsequently, on May 30, 2025, Rick Parod resigned as a member of the Board, effective immediately. As a result of the resignations, the Board currently has four directors.

*2025 Public Offering* 

On July 30, 2025, we entered into an underwriting agreement with Canaccord Genuity LLC, as underwriter, relating to an underwritten public offering of 21,980,000 shares of common stock, at a price to the public of $0.25 per share. On July 31, 2025, we completed the 2025 Public Offering raising gross proceed of approximately $5.5 million and net proceeds of $5.035 million after deducting underwriting discounts and commissions and other estimated offering expenses payable by us.

**Key Factors Affecting Our Operating Results**

Our financial position and results of operations depend to a significant extent on the following factors:

***End Market Consumers***

The demand for our products ultimately depends on demand from consumers in our current end markets. We generate sales through (1) DTC and (2) through OEMs, particularly in the RV market.

An increasing proportion of our sales has been and is expected to continue to be derived from sales to RV OEMs, driven by continued efforts to develop and expand sales to RV OEMs with whom we have longstanding relationships. Our RV OEM sales have been on a purchase order basis, without firm revenue commitments, and we expect that this will likely continue to be the case. Therefore, future RV OEM sales will be subject to risks and uncertainties, including the number of RVs these OEMs manufacture and sell, which in turn may be driven by the expectations these OEMs have around end market consumer demand.

Demand from end market consumers is impacted by a number of factors, including travel restrictions, fuel costs and energy demands (including an increasing trend towards the use of green energy), as well as overall macro-economic conditions and inflation. Sales of our batteries have benefited from the increased adoption of the RV lifestyle, the demand for and inclusion of additional appliances and electronics in RVs, and the accelerating trend of solar power adoption among RV customers. However, macro-economic conditions and increased competition from imported battery packs have led to a decrease in direct to consumer sales. We have addressed this decrease through product diversification by the release of our Dragonfly IntelLigence feature, as well as more targeted marketing efforts to increase the efficiency of our marketing spend. We expect that direct to consumer sales will remain relatively flat through 2025. However, we expect growth among our existing RV OEM customers due to an overall increase in RV shipments as our customers expanding the number of models that will include our battery systems in the new model year. Moreover, we expect increased revenue through our market diversification efforts – especially in our industrials market, including industrial solar and oil and gas, as well as the trucking market, in which we have been piloting our systems with fleets for the last two years.

Our strategy includes plans to expand into new end markets that we have identified as opportunities for our LFP batteries, including, rail, specialty and work vehicles, material handling, solar integration, and emergency and standby power, in the medium term, and data centers, telecom and distributed on-grid storage in the longer term. We believe that our current LFP batteries and, eventually, our solid-state batteries, will be well-suited to supplant traditional lead-acid batteries as a reliable power source for the variety of low power density uses required in these markets (such as powering the increasing number of on-board tools needed in emergency vehicles). The success of this strategy requires (1) continued growth of these addressable markets in line with our expectations and (2) our ability to successfully enter these markets. We expect to incur significant marketing costs understanding these new markets, and researching and targeting customers in these end markets, which may not result in sales. If we fail to execute on this growth strategy in accordance with our expectations, our sales growth would be limited to the growth of existing products and existing end markets.

***Supply***

We currently rely on two carefully selected cell manufacturers located in China, and a single supplier, also located in China, to manufacture our proprietary battery management system. Our close working relationships with our China-based LFP cell suppliers, reflected in our ability to increase our purchase order volumes (qualifying us for related volume-based discounts) and order and receive delivery of cells in anticipation of required demand, has helped us moderate increased supply-related costs associated with inflation, currency fluctuations and U.S. government tariffs imposed on our imported battery cells and to avoid potential shipment delays. To mitigate against potential adverse production events, we opted to build our inventory of key components, such as battery cells. However, as many of the supply chain challenges and delays that were prevalent over the last several years have eased, we are actively working down our inventory to more appropriate safety stock levels.

As a result of our battery chemistry and active steps we have taken to manage our inventory levels, we have not been subject to the shortages or price impacts that have been present for manufacturers of nickel manganese cobalt and nickel cobalt aluminum batteries. As we look toward the production of our solid-state cells, we have signed a Commercial Offtake Agreement with a lithium mining company located in Nevada for the supply of lithium, which we expect will enable us to further manage our cost of goods over time.

***Product and Customer Mix***

Our product sales consist of sales of seven different models of LFP batteries, along with accessories for battery systems (individually or bundled). These products are sold to different customer types (e.g., consumers, OEMs and distributors) and at different prices and involve varying levels of costs. In any particular period, changes in the mix and volume of particular products sold and the prices of those products relative to other products will impact our average selling price and our cost of goods sold. Despite our work to moderate increased supply-related costs, the price of our products may also increase as a result of increases in the cost of components due to inflation, currency fluctuations and tariffs. OEM sales typically result in lower average selling prices and related margins, which could result in margin erosion, negatively impact our growth or require us to raise our prices. However, this reduction is typically offset by the benefits of increased sales volumes. Sales of third-party sourced accessories typically have lower related margin. We expect accessory sales to increase as we further develop full-system design expertise and product offerings and consumers increasingly demand more sophisticated systems, rather than simple drop-in replacements. In addition to the impacts attributable to the general sales mix across our products and accessories, our results of operations are impacted by the relative margins of products sold. As we continue to introduce new products at varying price points, our overall gross margin may vary from period to period as a result of changes in product and customer mix.

***Production Capacity***

All of our battery assembly currently takes place at our 390,240 square foot headquarters and manufacturing facility located in Reno, Nevada. While the lease for the 99,000 facility is continuing, no manufacturing is taking place in this location. We currently operate three LFP battery production lines. Consistent with our operating history, we plan to continue to automate additional aspects of our battery production lines. Our existing facility has the capacity to add up to four additional LFP battery production lines and construct and operate a pilot production line for our solid-state cells, all designed to maximize the capacity of our manufacturing facility. Although our automation efforts are expected to reduce our costs of goods, we may not fully recognize the anticipated savings when planned and could experience additional costs or disruptions to our production activities. We have also focused on optimizing our manufacturing efficiency and throughput, enabling us to increase our production capacity without the need for increased headcount.

***Competition***

We compete with traditional lead-acid battery manufacturers and lithium-ion battery manufacturers, who primarily either import their products or components or manufacture products under a private label. As we continue to expand into new markets, develop new products and move towards production of our own conventional LFP cells and, in the longer term, solid state cells, we will experience competition with a wider range of companies. These competitors may have greater resources than we do and may be able to devote greater resources to the development of their current and future technologies. Our competitors may be able to source materials and components at lower costs, which may require us to evaluate measures to reduce our own costs, lower the price of our products or increase sales volumes in order to maintain our expected levels of profitability.

***Research and Development***

Our research and development is currently primarily focused on the scaling our proprietary dry electrode process for domestic production of full LFP cells. Although we have reallocated resources from the advanced manufacturing of solid-state lithium-ion batteries in order to focus on conventional cells, we expect to return to the solid-state chemistry as capital becomes more available for these longer term projects.

**Components of Results of Operations**

***Net Sales***

Net sales are primarily generated from the sale of our LFP batteries to OEMs and directly to consumers, as well as chargers and other accessories, either individually or bundled.

***Cost of Goods Sold***

Cost of goods sold includes the cost of cells and other components of our LFP batteries, labor and overhead, logistics and freight costs, and depreciation of manufacturing equipment.

***Gross Profit***

Gross profit, calculated as net sales less cost of goods sold, may vary between periods and is primarily affected by various factors including average selling prices, product costs, product mix and customer mix.

***Operating Expenses***

*Research and development*

Research and development costs include personnel-related expenses for scientists, experienced engineers and technicians as well as the material and supplies to support the development of new products and our solid-state technology.

*General and administrative*

General and administrative costs include personnel-related expenses attributable to our executive, finance, human resources, and information technology organizations, certain facility costs, and fees for professional services.

*Selling and marketing*

Selling and marketing costs include outbound freight, personnel-related expenses, as well as trade show, industry event, marketing, customer support, and other indirect costs. We expect to continue to make the necessary sales and marketing investments to enable the execution of our strategy, which includes expanding into additional end markets.

***Total Other Income (Expense)***

Other income (expense) consists primarily of interest expense, the change in fair value of the warrant liability and amortization of debt issuance costs.

**Results of Operations**

***Comparisons for the Three months ended June 30, 2025, and June 30, 2024***

The following table sets forth our results of operations for the three months ended June 30, 2025 and June 30, 2024. This data should be read together with our financial statements and related notes included elsewhere in this Quarterly Report, and is qualified in its entirety by reference to such financial statements and related notes.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** |
|  | **2025** | **% Net Sales** | **2024** | **% Net Sales** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Net Sales** | $16248 | 100.0 | $13208 | 100.0 |
| Cost of Goods Sold | 11643 | 71.7 | 10041 | 76.0 |
| **Gross profit** | 4605 | 28.3 | 3167 | 24.0 |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 692 | 4.3 | 1531 | 11.6 |
| &nbsp;&nbsp;&nbsp;General and administrative | 4619 | 28.4 | 5704 | 43.2 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 2575 | 15.8 | 2681 | 20.3 |
| **Total Operating expenses** | 7886 | 48.5 | 9916 | 75.1 |
| **Loss From Operations** | (3281) | (20.2) | (6749) | (51.1) |
| Other Income (Expense) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (5442) | (33.5) | (4878) | (37.0) |
| &nbsp;&nbsp;&nbsp;Other expense |  |  | (19) | (0.1) |
| &nbsp;&nbsp;&nbsp;Change in fair market value of warrant liability | 1689 | 10.4 | (1981) | (15.0) |
| **Total Other Expense** | (3753) | (23.1) | (6878) | (52.1) |
| **Loss Before Taxes** | (7034) | (43.3) | (13627) | (103.2) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Loss** | $(7034) | (43.3) | $(13627) | (103.2) |

---

---

| | | |
|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| DTC | 5948 | 6534 |
| % Net Sales | 36.6 | 49.5 |
| OEM | 10050 | 6674 |
| % Net Sales | 61.9 | 50.5 |
| Licensing Fee | 250 |  |
| % Net Sales | 1.5 |  |
| Net Sales | $16248 | 13208 |

---

***Net Sales***

Net sales increased by 3.0 million, or 23.0%, to $16.2 million for the three months ended June 30, 2025, as compared to $13.2 million for the three months ended June 30, 2024. This increase was primarily due to higher OEM battery and accessory sales of new models to existing customers and licensing revenue which is part of the Stryten agreement entered into the second half of 2024. We expect our sales to increase in the coming quarters as our customers expand the number of models they include our battery systems in for the new model year and our entrance into new markets, trucking and industrials, with new product offerings.

***Cost of Goods Sold***

Cost of goods sold increased by $1.6 million, or 16.0%, to $11.6 million for the three months ended June 30, 2025, as compared to $10.0 million for the three months ended June 30, 2024. This increase was primarily due to higher unit volume partially offset by lower material costs associated with consuming lower-priced inventory, resulting in a $1.6 million increase in product cost. We expect our Cost of Goods Sold to increase in conjunction with the anticipated increase in revenue along with increased product costs related to higher tariffs over the next 12 months.

***Gross Profit***

Gross profit increased by $1.4 million, or 45.4%, to $4.6 million for the three months ended June 30, 2025, as compared to $3.2 million for the three months ended June 30, 2024. The increase in gross profit was primarily due to a higher unit volume of sales partially offset by consumption of lower-priced inventory.

***Research and Development Expenses***

Research and development expenses decreased by $0.8 million, or 54.7%, to $0.7 million for the three months ended June 30, 2025, as compared to $1.5 million for the three months ended June 30, 2024. The decrease was primarily a result of lower wage expense in the amount of $0.6 million due to change in bonus accrual and reduced headcount. We expect Research and Development expenses to be lower than last year as we change our focus from Solid State to Product Development.

***General and Administrative Expenses***

General and administrative expenses decreased by $1.1 million, or 19.0%, to $4.6 million for the three months ended June 30, 2025, as compared to $5.7 million for the three months ended June 30, 2024. This decrease was primarily due to a decrease in legal and professional services of $1.5 million. Offsetting these lower costs is an increase wage expense due to increased headcount associated with the focus on product development and an increase in depreciation related to tenant improvements on the new facility. We expect General and Administrative Expenses, as a percentage of revenue, to be relatively stable over the next 12 months.

***Selling and Marketing Expenses***

Sales and marketing expenses decreased by $0.1 million, or 4.0%, to $2.6 million for the three months ended June 30, 2025, as compared to $2.7 million for the three months ended June 30, 2024. This decrease was primarily due to lower employee-related costs in the amount of $0.3 million partially offset by higher shipping costs in the amount of $0.2 million related to an increase in sales volume. We expect our Selling and Marketing Expenses to be relatively stable over the next 12 months.

***Total Other (Expense) Income***

Other expense totaled $3.8 million for the three months ended June 30, 2025 as compared to total other expense of $6.9 million for the three months ended June 30, 2024. Other expense of $3.8 million in three months ended June 30, 2025 was comprised primarily of interest expense of $5.4 million related to our debt securities partially offset by a change in fair market value of warrant liability in the amount of $1.7 million. The $6.9 million of other expense in three months ended June 30, 2024 was comprised primarily of interest expense of $4.9 million related to our debt securities and a negative change in fair market value of warrant liability in the amount of $2.0 million.

 ****

***Income Tax (Benefit) Expense***

There was no tax expense recorded for the three months ended June 30, 2025 or the three months ended June 30, 2024. Based on available evidence as of June 30, 2025 and June 30, 2024, management believes it is more likely than not that some or all the deferred tax assets will not be realized. Accordingly, we established a 100% valuation allowance. As a result of the full valuation allowance, we did not record a tax benefit during the three months ended June 30, 2025 or the three months ended June 30, 2024.

***Net Loss***

We experienced a net loss of $7.0 million for the three months ended June 30, 2025, as compared to net loss of $13.6 million for the three months ended June 30, 2024. As described above, this result was driven by higher sales, consumption of lower-priced inventory, lower operating expenses, and a decrease in other income (due to the change in fair market value of our warrants).

***Comparisons for the Six months ended June 30, 2025 and June 30, 2024***

The following table sets forth our results of operations for the six months ended June 30, 2025, and the six months ended June 30, 2024. This data should be read together with our financial statements and related notes included elsewhere in this Quarterly Report, and is qualified in its entirety by reference to such financial statements and related notes.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **% Net Sales** | **2024** | **% Net Sales** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Net Sales** | $29604 | 100.0 | $25713 | 100.0 |
| Cost of Goods Sold | 21071 | 71.2 | 19495 | 75.8 |
| **Gross profit** | 8533 | 28.8 | 6218 | 24.2 |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 1692 | 5.7 | 2864 | 11.1 |
| &nbsp;&nbsp;&nbsp;General and administrative | 10976 | 37.1 | 10517 | 40.9 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 5060 | 17.1 | 5425 | 21.1 |
| **Total Operating expenses** | 17728 | 59.9 | 18806 | 73.1 |
| **(Loss) From Operations** | (9195) | (31.1) | (12588) | (48.9) |
| Other Income (Expense) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | (10143) | (34.3) | (9638) | (37.5) |
| &nbsp;&nbsp;&nbsp;Other expense |  |  | (23) | (0.1) |
| &nbsp;&nbsp;&nbsp;Change in fair market value of warrant liability | 5507 | 18.6 | (1745) | (6.8) |
| **Total Other (Expense) Income** | (4636) | (15.7) | (11406) | (44.4) |
| **Loss Before Taxes** | (13831) | (46.7) | (23994) | (93.3) |
| **Income Tax Benefit** | - | - | - | - |
| **Net Loss** | $(13831) | (46.7) | $(23994) | (93.3) |

---

---

| | | |
|:---|:---|:---|
|  | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| DTC | 10963 | 11737 |
| % Net Sales | 37.0 | 45.6 |
| OEM | 18141 | 13976 |
| &nbsp;&nbsp;&nbsp;% Net Sales | 61.3 | 54.4 |
| &nbsp;&nbsp;&nbsp;Licensing fee | 500 |  |
| &nbsp;&nbsp;&nbsp;% Net Sales | 1.7 |  |
| Net Sales | $29604 | 25713 |

---

***Net Sales***

Net sales increased by $3.9 million, or 15.1%, to $29.6 million for the six months ended June 30, 2025, as compared to $25.7 million for the six months ended June 30, 2024. This increase was primarily due to higher OEM battery and accessory sales of new models to existing customers and licensing revenue which is part of the Stryten agreement entered into the second half of 2024. The decrease in DTC sales was due to ongoing macroeconomic pressures. We expect our sales to increase in the coming quarters as our customers expand the number of models they include our battery systems in for the new model year and our entrance into new markets, trucking and industrials, with new product offerings.

***Cost of Goods Sold***

Cost of goods sold increased by $1.6 million, or 8.1%, to $21.1 million for the six months ended June 30, 2025, as compared to $19.5 million for the six months ended June 30, 2024. This increase was primarily due to higher unit volume partially offset by lower material costs associated with consuming lower-priced inventory resulting in a $1.6 million increase in product cost. We expect our Cost of Goods Sold to increase in conjunction with the anticipated increase in revenue and higher tariffs over the next 12 months.

***Gross Profit***

Gross profit increased by $2.3 million, or 37.2%, to $8.5 million for the six months ended June 30, 2025, as compared to $6.2 million for the six months ended June 30, 2024. The increase in gross profit was primarily due to a higher unit volume of sales partially offset by consumption of lower-priced inventory.

***Research and Development Expenses***

Research and development expenses decreased by $1.2 million or 40.9%, to $1.7 million for the six months ended June 30, 2025, as compared to $2.9 million for the six months ended June 30, 2024. The decrease was primarily a result of lower wage expense in the amount of $0.9 million due to change in bonus accrual and reduced headcount along with lower rent, travel and supplies. We expect Research and Development expenses to be lower than last year as we change our focus from Solid State to Product Development.

 ****

***General and Administrative Expenses***

General and administrative expenses decreased by $0.5 million, or 4.4%, to $11.0 million for the six months ended June 30, 2025, as compared to $10.5 million for the six months ended June 30, 2024. This decrease was primarily due to a decrease in legal and professional services of $0.7 million and lower employee related costs in the amount of $0.2 million partially offset by higher rent in the amount of $0.5 million. We expect General and Administrative Expenses, as a percentage of revenue, to be relatively stable over the next 12 months.

***Selling and Marketing Expenses***

Sales and marketing expenses decreased by $0.3 million, or 6.7%, to $5.1 million for the six months ended June 30, 2025, as compared to $5.4 million for the six months ended June 30, 2024. This decrease was primarily due to lower employee related costs in the amount of $0.6 million primarily related to a change in bonus accrual and lower headcount. Partially offsetting this decrease is higher shipping costs in the amount of $0.1 million related to an increase in units sold along with higher spend on advertising. We expected Selling and Marketing Expenses, as a percentage of revenue, to be relatively stable over the next 12 months.

***Total Other Income (Expense)***

Other expense totaled $4.6 million for the six months ended June 30, 2025 as compared to total other expense of $11.4 million for the six months ended June 30, 2024. Other expense for the six months ended June 30, 2025 is comprised of $10.1 million in interest expense related to our debt securities partially offset by a change in fair market value of our warrants in the amount of $5.5 million. Other expense for the six months ended June 30, 2024 is comprised of a negative change in fair market value of our warrants in the amount of $1.7 million and $9.6 million in interest expense related to our debt securities.

***Income Tax (Benefit) Expense***

There was no tax expense recorded for the six months ended June 30, 2025 or the six months ended June 30, 2024. Based on available evidence as of June 30, 2025 and June 30, 2024, management believes it is more likely than not that some or all the deferred tax assets will not be realized. Accordingly, we established a 100% valuation allowance. As a result of the full valuation allowance, we did not record a tax benefit during the six months ended June 30, 2025 or the six months ended June 30, 2024.

***Net Loss***

We generated a net loss of $13.8 million for the six months ended June 30, 2025, as compared to net loss of $24.0 million for the six months ended June 30, 2024. As described above, this result was driven by higher sales, consumption of lower-priced inventory, lower operating expenses, and an increase in other expense , due to the change in fair market value of our warrants.

***Critical Accounting Estimates***

Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires us to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates under different assumptions or conditions. On a recurring basis, we evaluate our judgments and estimates in light of changes in circumstances, facts, and experience. The effects of material revisions in an estimate, if any, will be reflected in the consolidated financial statements prospectively from the date of the change in the estimate.

We consider an accounting estimate to be critical if: (1) the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and (2) changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.

Management has discussed the development and selection of these critical accounting estimates with the Audit Committee of our board of directors. In addition, there are other items within our financial statements that require estimation but are not deemed critical as defined above. Changes in estimates used in these and other items could have a material impact on our financial statements.

We believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

***Inventory Valuation***

We periodically review physical inventory for excess, obsolete, and potentially impaired items and reserves. Any such inventory is written down to net realizable value. The reserve estimate for excess and obsolete inventory is dependent on expected future use and requires management judgement. The level of the estimate is assessed by considering the recent sales experience, the aging of inventories, and other factors that affect inventory obsolescence

***Warrants***

We apply relevant accounting guidance for warrants to purchase our stock based on the nature of the relationship with the counterparty. For warrants issued to investors or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, Distinguishing Liabilities from Equity ("ASC 480"), and ASC 815, Derivatives and Hedging ("ASC 815"), to assist in the determination of whether the warrants should be classified as liabilities or equity. Warrants that are determined to require liability classifications are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications are measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified. See "*Note 9—Warrants*" in our accompanying condensed consolidated financial statements for information on the warrants. Changes in assumptions used to estimate fair value could occur from stock pricing volatility depending on our performance and our position in the industry and changes in market interest rates which can result in materially different results.

 ****

***Equity-Based Compensation***

We use the Black-Scholes option-pricing model to determine the fair value of option grants. In estimating fair value, management is required to make certain assumptions and estimates such as the expected life of units, volatility of our future share price, risk-free rates, future dividend yields and estimated forfeitures at the initial grant date. Restricted stock unit awards are valued based on the closing trading price of our common stock on the date of grant. Changes in assumptions used to estimate fair value could occur from stock pricing volatility depending on our performance and our position in the industry and changes in market interest rates which can result in materially different results.

***Income Taxes***

We account for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted rates. The effect of a change in tax rates on deferred taxes is recognized in income in the period that includes the enactment date.

We recognize the financial statement effect of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Recognized income tax positions are measured at the largest amount that is greater than 50% likely to be realized. A valuation allowance is recorded to reduce deferred income tax assets to an amount, which in the opinion of management is more likely than not to be realized.

Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. We consider factors such as the cumulative income or loss in recent years; reversal of deferred tax liabilities; projected future taxable income exclusive of temporary differences; the character of the income tax asset, including income tax positions; tax planning strategies and the period over which we expect the deferred tax assets to be recovered in the determination of the valuation allowance. In the event that actual results differ from these estimates or we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial position and results of operations.

The amount of the deferred tax asset considered realizable could be adjusted if our actual results in the future do not generate taxable income that is sufficient to allow us to utilize our deferred tax assets. Our future taxable income projections are subject to a high degree of uncertainty and could be impacted, both positively and negatively, by changes in our business or the markets in which we operate. A change in the assessment of the realizability of our deferred tax assets could materially impact our results of operations.

***Leases***

Acquired right-of-use assets and assumed lease liabilities are measured based on the remaining lease payments over the remaining portion of the lease term. As our leases do not provide an implicit rate, our incremental borrowing rate is used as a discount rate in determining the present value of lease payments. Our incremental borrowing rate was determined by comparing current low- and high-end mortgage loan rates and calculating an average. To be conservative in our estimate, we chose to use the high-end average as our incremental borrowing rate for all lease arrangements.

***License Arrangement***

We have entered into license arrangements that involve receiving upfront compensation, which is recognized as revenue over a five-year period. Management estimates the appropriate recognition pattern based on the expected delivery of related services and the period over which the economic benefits will be realized. This estimate involves judgments about the timing of performance obligations and the likelihood of continued customer engagement. Changes in these assumptions or unexpected developments could result in adjustments to revenue recognition, impacting the financial statements. As of the reporting date, management believes the estimate reflects the current understanding of the license arrangements' performance obligations.

***Tariffs***

We import certain components used in the manufacturing of our products and are responsible for calculating and paying the applicable tariffs. Tariff obligations involve significant judgment, including interpretation of customs classifications, trade agreements, and dutiable values.

**Non-GAAP Financial Measures**

This Quarterly Report includes a non-generally accepted account principles within the United States ("**U.S. GAAP**") measure that we use to supplement our results presented in accordance with U.S. GAAP. Earnings before interest tax and amortization ("**EBITDA**") is defined as earnings before interest and other income (expenses), income taxes, and depreciation and amortization. Adjusted EBITDA is calculated as EBITDA adjusted for stock-based compensation, change in fair market value of warrant liabilities, non-recurring costs associated with strategic financing, reverse stock split, litigation and loss on settlement. Adjusted EBITDA is a performance measure that we believe is useful to investors and analysts because it illustrates the underlying financial and business trends relating to our core, recurring results of operations and enhances comparability between periods.

Adjusted EBITDA is not a recognized measure under U.S. GAAP and is not intended to be a substitute for any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry. Investors should exercise caution in comparing our non-GAAP measure to any similarly titled measure used by other companies. This non-GAAP measure excludes certain items required by U.S. GAAP and should not be considered as an alternative to information reported in accordance with U.S. GAAP.

The table below presents our adjusted EBITDA, reconciled to net (loss) income for the three and six months ended June 30, 2025, and June 30, 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended**<br> **June 30,** | **Three months ended**<br> **June 30,** | **Six months ended**<br> **June 30,** | **Six months ended**<br> **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Net loss | $(7034) | $(13627) | $(13831) | $(23994) |
| &nbsp;&nbsp;&nbsp;Interest Expense | 5442 | 4878 | 10143 | 9638 |
| &nbsp;&nbsp;&nbsp;Depreciation and Amortization | 491 | 331 | 1350 | 663 |
| EBITDA | (1101) | (8418) | (2338) | (13693) |
| Adjusted for: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Stock-Based Compensation <sup>(1)</sup> | 190 | 237 | 411 | 503 |
| &nbsp;&nbsp;&nbsp;Change in fair market value of warrant liability <sup>(2)</sup> | (1689) | 1981 | (5507) | 1745 |
| &nbsp;&nbsp;&nbsp;Non-Recurring/One-Time Expenses:  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Litigation Fees and loss on settlement <sup>(3)</sup> | 30 |  | 573 |  |
| &nbsp;&nbsp;&nbsp;Prior year tariff estimate adjustment<sup>(4)</sup> | 287 |  | 287 |  |
| &nbsp;&nbsp;&nbsp;Preferred Stock Financing Expenses<sup>(5)</sup> | 42 |  | 673 |  |
| &nbsp;&nbsp;&nbsp;Reverse Stock Split<sup>(6)</sup> | - | - | 15 | - |
| **Adjusted EBITDA** | $(2241) | $(6200) | $(5886) | $(11445) |

---

(1) Stock-Based
 Compensation is comprised of costs associated with option and RSU grants made to our employees, consultants and board members.

(2) Change in fair market value
 of warrant liabilities represents the change in fair value from January 1, 2025 through June 30, 2025 and January 1, 2024 through
 June 30, 2024, respectively.

(3) Litigation Fees and Loss
 on Settlement includes legal fees and expenses and settlement related to the International Trade Commission 'ITC' Lithium
 Hub patent infringement case and other.

(4) Revision
 to estimate of prior year tariff underpayment

(5) Preferred
 Stock Financing is comprised of the expense relating to the Offerings

(6) Reverse Stock Split includes
 transfer agent and legal expenses and fees related to the reverse stock split with the SEC.

**Liquidity and Capital Resources**

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our cash flows from operations and their sufficiency to fund our operating and investing activities. As of June 30, 2025, we had cash totaling $2.7 million.

In February 2025, we raised $3.5 million with net proceeds of $3.2 million in connection with the sale of the shares of our Series A Preferred Stock, and raised an additional $4.5 million with net proceeds of $4.2 million in connection with the second closing of shares of our Series A Preferred Stock in April 2025.

On July 30, 2025, we entered into an underwriting agreement with Canaccord Genuity LLC, as underwriter, relating to an underwritten public offering of 21,980,000 shares of common stock, at a price to the public of $0.25 per share. On July 31, 2025, we completed the 2025 Public Offering raising gross proceed of approximately $5.5 million and net proceeds of $5.035 million after deducting underwriting discounts and commissions and other estimated offering expenses payable by us.

On July 29, 2024, Legacy Dragonfly and Battle Born LLC entered into the License with Stryten. In exchange for the licensing rights, Stryten agreed to pay Battle Born LLC the Initial Licensing Fee of five million dollars ($5,000,000). Per the License Agreement, payment for the Initial Licensing Fee is due within 30 days of the effective date of the License Agreement. We received the Initial Licensing Fee in August 2024.

We expect that we will need to raise additional funds, including through the issuance of equity, equity-related or debt securities or by obtaining additional credit from financial institutions to fund, together with our principal sources of liquidity, ongoing costs, such as research and development relating to our solid-state batteries, expansion of our facilities, and new strategic investments. If such financings are not available, or if the terms of such financings are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including by not seeking potential acquisition opportunities, eliminating redundancies, or reducing or delaying our production facility expansions, reduce operations, sell off our assets, seek the protection of bankruptcy courts or shut down our operations and dissolve. Further, any future debt or equity financings may be dilutive to our current stockholders.

***Financing Obligations and Requirements***

On November 24, 2021, we issued $45 million of fixed rate senior notes, secured by among other things, a security interest in our intellectual property. As part of the Business Combination, we entered into a senior secured term loan facility in an aggregate principal amount of $75 million (the "Term Loan") pursuant to the Term Loan, Guarantee and Security Agreement (the "Original Term Loan Agreement") by and among, us, Legacy Dragonfly, Alter Domus (US) LLC, as the Agent to the lenders time-to-time party thereto (such lenders, the "Term Loan Lenders"), the proceeds of which were used to repay the $45 million fixed rate senior notes, and ChEF Equity Facility. On June 28, 2024, we entered into the First Amendment with the Term Loan Lenders. The First Amendment provided for a one-time issuance of the June 2024 Penny Warrants to purchase up to 233,334 shares of common stock and certain amendments to the Term Loan. On July 29, 2024, we entered into the Second Amendment with the Term Loan Lenders in connection with the License Agreement. On September 30, 2024, we entered into the Third Amendment with the Term Loan Lenders, which provided for the issuance of the September 2024 Penny Warrants to purchase up to 333,334 shares of common stock and certain amendments to the Term Loan Agreement. On December 31, 2024, we entered into the Fourth Amendment with the Term Loan Lenders, which provided for the issuance of the December 2024 Penny Warrants to purchase up to 350,000 shares of common stock and certain amendments to the Term Loan Agreement. On February 26, 2025, we entered into the Fifth Amendment with the Term Loan Lenders, which provided for the issuance of the February 2025 Penny Warrants to purchase up to 330,000 shares of common stock and certain amendments to the Term Loan Agreement.

In connection with the License Agreement, on July 29, 2024, us, Legacy Dragonfly and Battle Born LLC entered into the Second Amendment (together with the Original Term Loan, the First Amendment, the Second Amendment, the Third Amendment and the Fourth Amendment, the "Term Loan Agreement").

Pursuant to the Second Amendment, the Term Loan Lenders (i) consented to the transactions contemplated by the License Agreement and the Trademark Transfer Agreement and (ii) agreed to waive the mandatory prepayment under the Term Loan that would have been due to the Term Loan Lenders under the Term Loan Agreement upon Battle Born LLC's receipt of the Initial Licensing Fee. In connection with the Second Amendment, Battle Born LLC entered into the Joinder.

The Term Loan proceeds were used to: (i) support the Business Combination, (ii) prepay the fixed rate senior notes at closing of the Business Combination, (iii) pay fees and expenses in connection with the foregoing, (iv) to provide additional growth capital and (v) for other general/corporate purposes. The Term Loan will mature on October 7, 2027, or the Maturity Date, and will be subject to quarterly amortization of 5% per annum beginning 24 months after issuance. The definitive documents for the Term Loan incorporate certain mandatory prepayment events and certain affirmative and negative covenants and exceptions hereto. The financial covenants for the Term Loan include a maximum senior leverage ratio covenant, a minimum liquidity covenant, a springing fixed charge coverage ratio covenant, and a maximum capital expenditures covenant. On March 29, 2023, September 29, 2023, December 29, 2023, May 13, 2024, June 28, 2024, September 30, 2024 and December 31, 2024, we obtained waivers from Alter Domus (US) LLC, as the administrative agent for the lenders (the "Administrative Agent") and EICF Agent LLC and certain third-party financing source of our failure to satisfy the Tests under the Term Loan during the quarters ended March 31, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024. On March 31, 2024, April 29, 2024, May 30, 2024, June 28, 2024, July 31, 2024, August 30, 2024, September 30, 2024, October 31, 2024, November 30, 2024, December 31, 2024 and January 31, 2025, we received additional waivers from the Administrative Agent and the Term Loan Lenders in regard to our compliance with the liquidity requirement under the Term Loan as of the last day of the fiscal quarters ended March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, and as of the last fiscal day for the months ended April 30, 2024, May 31, 2024, July 31, 2024, August 31, 2024, October 31, 2024 and November 30, 2024. However, it is probable that we will fail to meet these covenants within the next twelve months. In accordance with U.S. GAAP, we reclassified our notes payable from a long-term liability to a current liability. The Term Loan accrues interest as follows: (i) until April 1, 2024, at a per annum rate equal to adjusted secured overnight financing rate ("SOFR") plus 7% payable in cash plus an amount ranging from 4.5% to 6.5%, depending on our senior leverage ratio; (ii) effective April 1, 2024 and thereafter, interest payable to certain lenders subject to regulations of the U.S. Small Business Administration ("SBA") with outstanding principal on that date of $30,846 will be limited to 14.0% per annum (except for default interest permitted under SBA regulations, as applicable); and (iii) the other outstanding principal will accrue interest from April 1, 2024 thereafter until October 1, 2024, at a per annum rate equal to adjusted SOFR plus 7% payable in cash plus an amount ranging from 4.5% to 6.5%, depending on the senior leverage ratio of the consolidated company, and at all times thereafter, at a per annum rate equal to adjusted SOFR plus a margin ranging from 11.5% to 13.5%, depending on our senior leverage ratio.

Payments of interest based on the Term Loan are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Interest payable on April
 1, 2024, was paid in cash.

(ii) Interest payable on July
 1, 2024, became payable-in-kind.

(iii) Interest payable on October
 1, 2024, became payable partly in cash and partly in-kind, at a per annum rate equal to adjusted SOFR plus 7% payable in cash plus
 an amount ranging from 4.5% to 6.5% paid-in-kind, depending on the senior leverage ratio of the consolidated company (subject to
 the 14.0% limit for lenders subject to SBA regulations).

(iv) Interest payable on January
 1, 2025 to December 31, 2025 will be payable in kind.

(v) Interest payable on April
 1, 2026 to October 7, 2027 will be payable in cash.

In each of the foregoing cases, adjusted SOFR will be no less than 1%.

We may elect to prepay all or any portion of the amounts owed prior to the Maturity Date, provided that we provide notice to the Administrative Agent and the amount is accompanied by the applicable prepayment premium, if any. Prepayments of the Term Loan are required to be accompanied by a premium of 5% of the principal amount so prepaid if made prior to October 7, 2023, 3% if made on and after October 7, 2023 but prior to October 7, 2024, 1% if made after October 7, 2024 but prior to October 7, 2025, and 0% if made on or after October 7, 2025. If the Term Loan is accelerated following the occurrence of an event of default, Legacy Dragonfly is required to immediately pay to lenders the sum of all obligations for principal, accrued interest, and the applicable prepayment premium.

Pursuant to the Term Loan Agreement, we have guaranteed the obligations of Legacy Dragonfly and such obligations will be guaranteed by any of Legacy Dragonfly's subsidiaries that are party thereto from time to time as guarantors. Also pursuant to the Term Loan Agreement, the Administrative Agent was granted a security interest in substantially all of the personal property, rights and assets of us as and Legacy Dragonfly to secure the payment of all amounts owed to lenders under the Term Loan Agreement. In addition, we entered into a Pledge Agreement pursuant to which we pledged to the Administrative Agent our equity interests in Legacy Dragonfly as further collateral security for the obligations under the Term Loan Agreement. At the closing of the Business Combination, we issued to the Term Loan Lenders (i) the Penny Warrants and (ii) the $10 Warrants.

Pursuant to the ChEF Purchase Agreement, on the terms of and subject to the satisfaction of the conditions in the ChEF Purchase Agreement, including the filing and effectiveness of a registration statement registering the resale by CCM LLC of the shares of common stock issued to it under the ChEF Purchase Agreement, and certain restrictions set forth in the Term Loan Agreement, we will have the right from time to time at our option to direct CCM LLC to purchase up to a specified maximum amount of shares of common stock, up to a maximum aggregate purchase price of $150 million over the term of the ChEF Equity Facility. In connection with the ChEF Equity Facility, we filed a registration statement registering the resale of up to 2,390,226 shares that may be resold into the public markets by CCM LLC, which represented approximately 33% of the shares of our common stock outstanding as of December 31, 2023. During the year ended December 31, 2023, we issued and sold approximately 65,389 shares of our common stock under this facility, resulting in net cash proceeds of $1,278,566. During the year ended December 31, 2024, we issued 350,423 shares pursuant to the ChEF Purchase Agreement with CCM LLC for aggregate proceeds to us of $2,043,885. During the six months ended June 30, 2025, we issued 23,160 shares pursuant to the ChEF Purchase Agreement for aggregate proceeds to us of $62,846. Subsequent to the quarter ended June 30, 2025, we have not issued any shares pursuant to the ChEF Purchase Agreement. This impact may be heightened by the fact that sales to CCM LLC will generally be at prices below the current trading price of our common stock. If the trading price of our common stock does not recover or experiences a further decline, sales of shares of common stock to CCM LLC pursuant to the ChEF Purchase Agreement may be a less attractive source of capital and/or may not allow us to raise capital at rates that would be possible if the trading price of our common stock were higher. The ChEF Purchase Agreement terminates in December 2025. In connection with the 2025 Public Offering, we agreed not to sell shares of our common stock for a period of 90 days following the closing of the offering, subject to certain exceptions

On January 30, 2024, we issued an unsecured convertible promissory note (the "January Note") in the principal amount of $1.0 million (the "January Principal Amount") to Brian Nelson, one of our directors, in a private placement in exchange for cash in an equal amount. The January Note became due and payable in full on February 2, 2024. We were also obligated to pay $50,000 (the "January Loan Fee") to Mr. Nelson on February 2, 2024. We paid the January Principal Amount and the January Loan Fee in full on February 2, 2024.

On February 27, 2024 we issued a convertible promissory (the "February Note") in the amount of $1.7 million (the "February Principal Amount") to Mr. Nelson, in a private placement in exchange for cash in an equal amount. The February Note became due and payable in full on March 1, 2024. We were also obligated to pay a $85,000 loan fee (the "February Loan Fee") to Mr. Nelson on March 1, 2024. We paid the February Principal Amount and the February Loan Fee on March 1, 2024.

In 2024, we identified an underpayment of tariffs to U.S. Customs and Border Protection ("CBP") in the amount of approximately $1.66 million in the aggregate, related to the improper classification and valuation of certain of the products used in our batteries. We have reported the underpayment to CBP. In June 2025, after a comprehensive review of this tariff calculation, an additional $0.29 million was discovered and also reported to CBP and a payment plan of $0.05 million per week was put into place.

**Going Concern**

For the quarter ended June 30, 2025, we generated a net loss of $7.0 million and had a negative cash flow from operations. As of June 30, 2025, we had approximately $2.7 million in cash and cash equivalents and working capital of $8.4 million.

Under the Term Loan Agreement, we are obligated to comply with certain financial covenants, which include maintaining a maximum senior leverage ratio, minimum liquidity, a springing fixed charge coverage ratio, and maximum capital expenditures. On March 31, 2024, April 29, 2024, May, 30, 2024, June 28, 2024, July 31, 2024, August 31, 2024, September 30, 2024, October 31, 2024, November 30, 2024, December 31, 2024 and January 31, 2025, we obtained waivers from the Administrative Agent and Term Loan Lenders of our failures to satisfy the liquidity requirement under the Term Loan for the quarters ended March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024 and the fiscal months ended April 30, 2024, May 31, 2024, July 31, 2024, August 31, 2024, October 31, 2024, and November 30, 2024, as applicable. In connection with the License Agreement, on July 29, 2024, us, Legacy Dragonfly and Battle Born LLC entered into the Second Amendment. Pursuant to the Second Amendment, the Term Loan Lenders (i) consented to the transactions contemplated by the License Agreement and the Trademark Transfer Agreement and (ii) agreed to waive the mandatory prepayment under the Loan Agreement that would have been due to the Lenders under the Term Loan upon Battle Born LLC's receipt of the Initial Licensing Fee. In connection with the Second Amendment, Battle Born LLC entered into the Joinder.

On September 30, 2024, we entered into the Third Amendment, which: (i) reduced the liquidity requirement under the Term Loan to be $7.0 million as of the last day of the month ended September 30, 2024, and $10.0 million as of the last day of each fiscal month thereafter commencing with the fiscal month ended July 31, 2024 and (ii) on October 1, 2024, interest is payable (a) $1,500,000 in cash for the pro rata benefit of the Lenders and (b) the remaining interest in-kind, to be capitalized and added to the principal. For Payment Dates occurring on or after January 1, 2025 (including interest accruing from October 1, 2024, through December 31, 2024), all interest shall be paid in cash at a rate equal to Adjusted Term SOFR plus the Applicable Margin.

On December 31, 2024, we entered into the Fourth Amendment, which: (i) reduced the liquidity requirement under the Term Loan to be $3.5 million as of the last day of the month ended December 31, 2024, and $10.0 million as of the last day of each fiscal month thereafter commencing with the fiscal month ended January 31, 2025 and (ii) on January 1, 2025, interest is payable in-kind, to be capitalized and added to the principal. For Payment Dates occurring on or after April 1, 2025 (including interest accruing from January 1, 2025, through March 31, 2025), all interest shall be paid in cash at a rate equal to Adjusted Term SOFR plus the Applicable Margin.

On February 26, 2025, in connection with the Purchase Agreement, we entered into the Fifth Amendment, which: (i) extended the maturity date by one year to October 2027, (ii) deferred all principal and interest payments to April 2026 and (iii) removed any applicable financial covenants (except for a financial covenant requiring us to maintain cash and cash equivalents equal to or greater than $2.5 million on a monthly basis) through June 30, 2026.

As presented above, strategic initiatives were executed in order to alleviate the substantial doubt, such as our ability to raise funds, the maturity extension of the Term Loan (which reclassified the loan as long-term on the financial statements for the year ending December 31, 2024), and the absence of any covenants, other than a $2,500 minimum cash requirement, for at least one year from the financial statement issuance date. However, the initiatives were not enough support to completely alleviate our going concern. Due to no other concessions being made by the lenders in terms of future debt and interest due, except for extending payments into 2026 and the maturity date by one year, and lack of substantial proof of revenue projections for new markets, management concluded that there is significant doubt about our ability to continue as a going concern.

As a result, our independent registered public accounting firm included an explanatory paragraph in its report on our 2024 consolidated financial statements, with respect to this uncertainty.

In addition, we may need to raise additional debt and/or equity financing to fund our operations and strategic plans and meet our financial covenants. We have historically been able to raise additional capital through issuance of equity and/or debt financing and we intend to raise additional capital as needed, subject to certain restrictions set forth in the Term Loan Agreement. However, we cannot guarantee that we will be able to raise additional equity, contain expenses, or increase revenue. If such financings are not available, or if the terms of such financings are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including by not seeking potential acquisition opportunities, eliminating redundancies, or reducing or delaying our production facility expansions, reduce operations, sell off our assets, seek the protection of bankruptcy courts or shut down our operations and dissolve, which may adversely affect our business, operating results, financial condition and prospects. Further, future debt or equity financings may be dilutive to our current stockholders.

***Cash Flows for the Six months ended June 30, 2025, and June 30, 2024***

---

| | | |
|:---|:---|:---|
|  | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| Net Cash (used in)/provided by: |  |  |
| Operating Activities | $(7865) | $(7411) |
| Investing activities | $(1621) | $(1324) |
| Financing activities | $7370 | $721 |

---

***Operating Activities***

Net cash used in operating activities was $7.9 million for the six months ended June 30, 2025, primarily due to a net loss of $13.8 million partially offset by $7.3 million of payment in-kind interest accrued on the Term Loan.

Net cash used in operating activities was $7.4 million for six months ended June 30, 2024, primarily due to a net loss of $24.0 million partially offset by $4.6 million of payment in-kind interest accrued on the Term Loan and $10.1 million decrease in inventory as a result of management's decision to lower overall stocking levels to adjust for more modest demand.

***Investing Activities***

Net cash used in investing activities was $1.6 million for the six months ended June 30, 2025, as compared to net cash used in investing activities of $1.3 million for the six months ended June 30, 2024. The increase in cash used in investing activities was primarily due to an increase in capital expenses to support our core battery business.

***Financing Activities***

Net cash provided by financing activities was $7.4 million for the six months ended June 30, 2025, primarily related to net proceeds of $7.3 million as part of the Purchase Agreement entered into in February 2025. This is compared to $0.7 million net cash provided in financing activities primarily from proceeds of issuing and selling shares under ChEF Equity Facility for the six months ended June 2024.

**Contractual Obligations**

Our estimated future obligations consist of short-term and long-term operating lease liabilities. As of June 30, 2025, we had $3.0 million in short-term operating lease and financing liabilities and $21.8 million in long-term operating and financing lease liabilities.

As disclosed above, we have a Term Loan and as of June 30, 2025, the principal amount outstanding under the Term Loan was $69.9 million.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Not applicable.

**ITEM 4. CONTROLS AND PROCEDURES**

*Evaluation of Disclosure Controls and Procedures*

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, and the rules and regulations thereunder, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) under the Exchange Act, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and implementation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2025. Based on that evaluation, management concluded that as of June 30, 2025, we did maintain effective disclosure controls and procedures.

*Changes in Internal Control over Financial Reporting*

No changes in our internal control over financial reporting (as defined by Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended June 30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

**ITEM 1A. RISK FACTORS**

*In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on June 30, 2025, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K may not be the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently deems to be immaterial also may materially adversely affect the Company's business, financial condition and/or operating results.*

*There were no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K except as noted below.*

***We are not currently in compliance with the continued listing requirements for The Nasdaq Capital Market. If we do not regain compliance and continue to meet the continued listing requirements, our common stock may be delisted, which could affect the market price and liquidity for our common stock and reduce our ability to raise additional capital.***

On December 12, 2024, we received a written notice (the "Notice") from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market, LLC ("Nasdaq") indicating that we are not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires us to maintain a minimum Market Value of Listed Securities ("MVLS") of $35 million for continued listing on The Nasdaq Capital Market (the "MVLS Requirement") for the 30 consecutive business days preceding receipt of the Notice.

On May 14, 2025, we received a letter (the "Letter") from the Staff indicating that, based upon our non-compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the "Bid Price Requirement"), the Staff had determined to delist our securities from Nasdaq unless we timely request a hearing before the Nasdaq Hearings Panel (the "Panel"). Pursuant to Listing Rule 5810(c)(3)(A)(iv), we are not eligible for any compliance period due to the fact that we have effected a reverse stock split over the prior one-year period. We timely requested a hearing before the Panel.

On June 11, 2025, we received an additional staff determination letter indicating that, based upon our non-compliance with the MVLS Requirement, the Staff had determined such non-compliance served as an additional basis for delisting our securities from Nasdaq. Additionally, as of the date of this report, we do not meet either of the alternative Nasdaq continued listing standards under the Nasdaq Listing Rules, stockholders' equity of $2,500,000, or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.

On July 2, 2025, following our hearing with the Panel on June 24, 2025, we received notice from Nasdaq that, based on the plan of compliance that we had submitted, the Panel had granted us an exception until November 10, 2025 (the "Exception") to regain compliance with the Bid Price Requirement and the MVLS Requirement, subject to our achievement of certain milestones, including the conversion by the holder of its remaining outstanding shares of our Series A Preferred Stock into shares of our common stock by July 18, 2025, which was completed, and the restructuring of a portion of our outstanding debt or conversion of such debt into shares of our common stock by mid-August 2025. In order to meet the $2,500,000 stockholders' equity alternative continued listing standard, we may need to raise additional capital depending on the amount of debt we may be able to convert, if any, with the Term Loan Lenders. We also may need to complete a reverse split of our outstanding common stock in order to meet the Bid Price Requirement. In the event we fail to meet these and other milestones set forth in the compliance plan submitted to the Panel or otherwise regain compliance with the Bid Price Requirement and the MVLS Requirement or the alternative criteria by November 10, 2025, our securities will be delisted from Nasdaq. There can be no assurance that we will be able to regain compliance with the Bid Price Requirement, the MVLS requirement, or maintain compliance even if we implement an option that regains our compliance. A delisting could substantially decrease trading in our common stock, adversely affect the market liquidity of our common stock as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws, result in a default under the terms of our outstanding indebtedness, adversely affect its ability to obtain financing on acceptable terms, if at all, and may result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities. Additionally, the market price of our common stock may decline further and stockholders may lose some or all of their investment.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

None.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

During the three months ended June 30, 2025, none of our directors or "officers" (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(c) of Regulation S-K.

**ITEM 6. EXHIBITS**

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Incorporation by Reference** | **Incorporation by Reference** | **Incorporation by Reference** |
| <br>**Exhibit No.** | <br>**Description** | **Form** | **Exhibit** | **Filing Date** |
| 3.1 | [Articles of Incorporation of Dragonfly Energy Holdings Corp.](https://www.sec.gov/Archives/edgar/data/1847986/000149315223010262/ex3-1.htm) | 8-K | 3.1 | 03/31/2023 |
| 3.2 | [Bylaws of Dragonfly Energy Holdings Corp.](https://www.sec.gov/Archives/edgar/data/1847986/000149315223010262/ex3-2.htm) | 8-K | 3.2 | 03/31/2023 |
| 3.3 | [Certificate of Amendment to the Articles of Incorporation of Dragonfly Energy Holdings Corp., dated April 25, 2025.](https://www.sec.gov/Archives/edgar/data/1847986/000164117225006463/ex3-1.htm) | 8-K | 3.1 | 04/28/2025 |
| 10.1 | [Form of Settlement and Mutual Release Agreement, dated July 20, 2025, by and between the Company and the investor party thereto.](https://www.sec.gov/Archives/edgar/data/1847986/000164117225020360/ex10-1.htm) | 8-K | 10.1 | 07/21/2025 |
| 31.1\* | [Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm) |  |  |  |
| 31.2\* | [Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm) |  |  |  |
| 32.1\*\* | [Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm) |  |  |  |
| 101.INS\* | Inline XBRL Instance Document. |  |  |  |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |  |  |  |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document. |  |  |  |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document. |  |  |  |
| 101.LAB\* | Inline XBRL Taxonomy Extension Labels Linkbase Document. |  |  |  |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |  |  |  |
| 104\* | Cover Page Interactive Data File (embedded within the Inline XBRL document and included as Exhibit 101). |  |  |  |

---

\* Filed herewith. <br> \*\* Furnished.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Dragonfly Energy Holdings Corp.** | **Dragonfly Energy Holdings Corp.** |
| Date: August 14, 2025 | By: | */s/ Denis Phares* |
|  |  | Denis Phares |
|  |  | Chief Executive Officer, President and Interim Chief Financial Officer |
|  |  | (Principal Executive Officer and Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Denis Phares, certify that:

1. I
 have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2025 of Dragonfly Energy Holdings Corp.;

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
 the period covered by this report;

3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
 respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
 this report

4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange
 Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared;

b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
 reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing
 the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| |
|:---|
| Date: August 14, 2025 |
| */s/ Denis Phares* |
| Chief Executive Officer |
| (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Denis Phares, certify that:

1. I
 have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2025 of Dragonfly Energy Holdings Corp.;

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
 the period covered by this report;

3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
 respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
 this report

4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange
 Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared;

b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
 reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing
 the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| |
|:---|
| Date: August 14, 2025 |
| */s/ Denis Phares* |
| Interim Chief Financial Officer |
| (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND**

**CHIEF FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

This Certification is being filed pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002. This Certification is included solely for the purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act and is not intended to be used for any other purpose. In connection with the accompanying Quarterly Report on Form 10-Q of Dragonfly Energy Holdings Corp. (the "**Company**") for the quarter ended June 30, 2025 (the "**Quarterly Report**"), Denis Phares, as Chief Executive Officer and Interim Chief Financial Officer, certifies in his capacity as such officer of the Company, that to his knowledge:

1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Dated: August 14, 2025 | Dated: August 14, 2025 |
| *By:* | */s/ Denis Phares* |
|  | Denis Phares |
|  | Chief Executive Officer and Interim Chief Financial Officer |
|  | (Principal Executive Officer and Principal Financial Officer) |

---

This certification shall not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.